Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:nitrogen oxide
go back to main search page
Accession:CHEBI:35196 term browser browse the term
Synonyms:related_synonym: nitrogen oxides;   oxides of nitrogen


show annotations for term's descendants           Sort by:
 
dinitrogen oxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cntf ciliary neurotrophic factor multiple interactions
decreases activity
ISO
EXP
Nitrous Oxide inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT1 protein]; Nitrous Oxide inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT3 protein]
Nitrous Oxide inhibits the reaction [CNTF protein results in increased activity of STAT3 protein]
Nitrous Oxide results in decreased activity of CNTF protein
CTD PMID:15748169 NCBI chr19:12,763,528...12,765,632
Ensembl chr19:12,763,660...12,765,632
JBrowse link
G Gabra4 gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4 multiple interactions EXP [Isoflurane co-treated with Nitrous Oxide] affects the expression of GABRA4 mRNA CTD PMID:16733821 NCBI chr 5:71,569,734...71,658,308
Ensembl chr 5:71,569,749...71,658,308
JBrowse link
G Grin2a glutamate receptor, ionotropic, NMDA2A (epsilon 1) multiple interactions EXP GRIN2A protein affects the susceptibility to [Nitrous Oxide co-treated with sevoflurane] CTD PMID:15731593 NCBI chr16:9,567,901...9,996,083
Ensembl chr16:9,567,898...9,995,560
JBrowse link
G Mtr 5-methyltetrahydrofolate-homocysteine methyltransferase decreases activity ISO Nitrous Oxide results in decreased activity of MTR protein CTD PMID:18472229 NCBI chr13:12,181,331...12,258,199
Ensembl chr13:12,182,712...12,258,113
JBrowse link
G Pla2g7 phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) affects expression ISO Nitrous Oxide affects the expression of PLA2G7 CTD PMID:21356620 NCBI chr17:43,567,994...43,612,202
Ensembl chr17:43,568,098...43,612,201
JBrowse link
G Pomc pro-opiomelanocortin-alpha increases secretion ISO Nitrous Oxide results in increased secretion of POMC protein CTD PMID:2846107 NCBI chr12:3,954,945...3,960,643
Ensembl chr12:3,954,951...3,960,642
JBrowse link
G Ren2 renin 2 tandem duplication of Ren1 affects abundance EXP REN2 protein affects the abundance of Nitrous Oxide CTD PMID:12512695
G Stat1 signal transducer and activator of transcription 1 multiple interactions ISO Nitrous Oxide inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT1 protein] CTD PMID:15748169 NCBI chr 1:52,119,438...52,161,865
Ensembl chr 1:52,119,440...52,161,865
JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions EXP
ISO
Nitrous Oxide inhibits the reaction [CNTF protein results in increased activity of STAT3 protein]
Nitrous Oxide inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT3 protein]
CTD PMID:15748169 NCBI chr11:100,886,806...100,939,594
Ensembl chr11:100,885,098...100,939,540
JBrowse link
nitric oxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 multiple interactions EXP ABCC1 protein affects the reaction [AGT protein results in decreased abundance of Nitric Oxide]; ABCC1 protein promotes the reaction [Nitric Oxide results in increased secretion of Glutathione]; ABCC1 protein promotes the reaction [Nitric Oxide results in increased secretion of Iron] CTD PMID:16679408 PMID:17272743 NCBI chr16:14,361,453...14,474,878
Ensembl chr16:14,361,558...14,475,737
JBrowse link
G Abcc2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 multiple interactions ISO ABCC2 affects the reaction [Ursodeoxycholic Acid results in increased secretion of Nitric Oxide]
ABCC2 gene SNP affects the susceptibility to [Air Pollutants results in increased abundance of Nitric Oxide]
CTD PMID:20683964 PMID:29681089 NCBI chr19:43,782,308...43,838,332
Ensembl chr19:43,782,192...43,840,740
JBrowse link
G Acbd3 acyl-Coenzyme A binding domain containing 3 multiple interactions ISO Nitric Oxide promotes the reaction [[RASD1 protein binds to ACBD3 protein binds to SLC11A2 protein] which results in increased uptake of Iron] CTD PMID:16908409 NCBI chr 1:180,726,043...180,754,204
Ensembl chr 1:180,726,043...180,754,204
JBrowse link
G Ace angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 multiple interactions
increases expression
ISO Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACE mRNA]; Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACE mRNA] CTD PMID:10948087 PMID:16326922 NCBI chr11:105,967,948...105,989,964
Ensembl chr11:105,967,945...105,989,964
JBrowse link
G Aco1 aconitase 1 decreases expression
multiple interactions
EXP Nitric Oxide results in decreased expression of ACO1 mRNA
STAT5A protein affects the reaction [Nitric Oxide results in decreased expression of ACO1 mRNA]; STAT5B protein affects the reaction [Nitric Oxide results in decreased expression of ACO1 mRNA]
CTD PMID:16886906 NCBI chr 4:40,143,265...40,199,009
Ensembl chr 4:40,143,081...40,198,338
JBrowse link
G Acta1 actin, alpha 1, skeletal muscle multiple interactions
increases expression
ISO Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACTA1 mRNA]; Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACTA1 mRNA] CTD PMID:10397678 PMID:16326922 NCBI chr 8:123,891,758...123,894,775
Ensembl chr 8:123,891,769...123,894,751
JBrowse link
G Actb actin, beta decreases expression EXP Nitric Oxide deficiency results in decreased expression of ACTB mRNA CTD PMID:15878706 NCBI chr 5:142,903,115...142,907,976
Ensembl chr 5:142,903,115...142,906,754
JBrowse link
G Adm adrenomedullin increases expression ISO Nitric Oxide deficiency results in increased expression of ADM mRNA CTD PMID:16326922 NCBI chr 7:110,627,657...110,629,820
Ensembl chr 7:110,627,661...110,629,820
JBrowse link
G Adm2 adrenomedullin 2 increases expression ISO Nitric Oxide deficiency results in increased expression of ADM2 mRNA CTD PMID:16326922 NCBI chr15:89,322,720...89,324,731
Ensembl chr15:89,322,720...89,324,731
JBrowse link
G Adrb2 adrenergic receptor, beta 2 decreases abundance EXP ADRB2 protein results in decreased abundance of Nitric Oxide CTD PMID:10580815 NCBI chr18:62,177,713...62,179,981
Ensembl chr18:62,177,816...62,179,959
JBrowse link
G Agt angiotensinogen (serpin peptidase inhibitor, clade A, member 8) decreases secretion
increases chemical synthesis
increases activity
increases abundance
increases secretion
decreases abundance
multiple interactions
ISO
EXP
AGT protein modified form results in decreased secretion of Nitric Oxide
AGT protein modified form results in increased chemical synthesis of Nitric Oxide
Nitric Oxide deficiency results in increased activity of AGT protein modified form
AGT protein results in increased abundance of Nitric Oxide
AGT protein alternative form results in increased secretion of Nitric Oxide
AGT protein results in decreased abundance of Nitric Oxide
AGT protein alternative form promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]; PD 123319 inhibits the reaction [AGT protein results in increased abundance of Nitric Oxide]; Valsartan inhibits the reaction [AGT protein results in increased abundance of Nitric Oxide]; Valsartan inhibits the reaction [AGT protein results in increased secretion of Nitric Oxide]
ABCC1 protein affects the reaction [AGT protein results in decreased abundance of Nitric Oxide]
candesartan inhibits the reaction [AGT protein results in increased chemical synthesis of Nitric Oxide]; Hydrogen Sulfide promotes the reaction [AGT protein modified form results in increased chemical synthesis of Nitric Oxide]; Losartan inhibits the reaction [AGT protein modified form results in decreased secretion of Nitric Oxide]; troglitazone inhibits the reaction [AGT protein modified form results in decreased secretion of Nitric Oxide]
CTD PMID:12198334 PMID:14597853 PMID:14620932 PMID:17272743 PMID:17666345 PMID:18551021 PMID:18990443 PMID:29084084 NCBI chr 8:124,556,587...124,569,706
Ensembl chr 8:124,556,534...124,569,706
JBrowse link
G Agtr1a angiotensin II receptor, type 1a affects abundance ISO AGTR1A protein affects the abundance of Nitric Oxide CTD PMID:19151255 NCBI chr13:30,336,356...30,382,867
Ensembl chr13:30,336,441...30,382,867
JBrowse link
G Agtr1b angiotensin II receptor, type 1b affects abundance ISO AGTR1B protein affects the abundance of Nitric Oxide CTD PMID:19151255 NCBI chr 3:20,314,473...20,367,177
Ensembl chr 3:20,314,473...20,367,177
JBrowse link
G Agtr2 angiotensin II receptor, type 2 affects response to substance ISO AGTR2 protein affects the susceptibility to Nitric Oxide CTD PMID:9374809 NCBI chr  X:21,484,624...21,488,833
Ensembl chr  X:21,484,544...21,489,164
JBrowse link
G Aifm1 apoptosis-inducing factor, mitochondrion-associated 1 affects localization ISO Nitric Oxide affects the localization of AIFM1 protein CTD PMID:15126337 NCBI chr  X:48,474,944...48,513,563
Ensembl chr  X:48,474,944...48,513,563
JBrowse link
G Aimp1 aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 increases expression EXP Nitric Oxide deficiency results in increased expression of AIMP1 mRNA CTD PMID:15878706 NCBI chr 3:132,660,498...132,684,390
Ensembl chr 3:132,660,481...132,684,370
JBrowse link
G Aip aryl-hydrocarbon receptor-interacting protein decreases expression EXP Nitric Oxide deficiency results in decreased expression of AIP mRNA CTD PMID:15878706 NCBI chr19:4,113,756...4,126,559
Ensembl chr19:4,114,446...4,125,858
JBrowse link
G Akt1 thymoma viral proto-oncogene 1 multiple interactions ISO AKT1 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Nitric Oxide] CTD PMID:18245901 NCBI chr12:112,653,821...112,674,884
Ensembl chr12:112,653,821...112,674,884
JBrowse link
G Aldh2 aldehyde dehydrogenase 2, mitochondrial multiple interactions EXP [ALDH2 protein affects the metabolism of and results in increased susceptibility to Pentaerythritol Tetranitrate] which results in increased abundance of Nitric Oxide CTD PMID:21156756 NCBI chr 5:121,566,027...121,593,824
Ensembl chr 5:121,566,027...121,593,824
JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions ISO Nitric Oxide promotes the reaction [Reactive Oxygen Species results in decreased activity of ALOX5 protein] CTD PMID:12388339 NCBI chr 6:116,410,071...116,461,178
Ensembl chr 6:116,410,077...116,461,178
JBrowse link
G Angptl2 angiopoietin-like 2 decreases chemical synthesis EXP ANGPTL2 gene mutant form results in decreased chemical synthesis of Nitric Oxide CTD PMID:27402837 NCBI chr 2:33,215,951...33,247,725
Ensembl chr 2:33,216,069...33,247,717
JBrowse link
G Anxa5 annexin A5 increases expression ISO Nitric Oxide results in increased expression of ANXA5 protein CTD PMID:16024610 NCBI chr 3:36,448,923...36,475,887
Ensembl chr 3:36,448,923...36,475,894
JBrowse link
G Apoe apolipoprotein E decreases chemical synthesis EXP APOE gene mutant form results in decreased chemical synthesis of Nitric Oxide CTD PMID:11397713 NCBI chr 7:19,696,244...19,701,310
Ensembl chr 7:19,696,109...19,699,188
JBrowse link
G App amyloid beta (A4) precursor protein multiple interactions EXP [APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; Ibuprofen inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Indomethacin inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] CTD PMID:11080519 NCBI chr16:84,952,666...85,175,255
Ensembl chr16:84,949,685...85,173,766
JBrowse link
G Aqp2 aquaporin 2 decreases expression ISO Nitric Oxide deficiency results in decreased expression of AQP2 protein CTD PMID:17940347 NCBI chr15:99,579,056...99,584,545
Ensembl chr15:99,579,055...99,584,547
JBrowse link
G Ass1 argininosuccinate synthetase 1 increases response to substance EXP ASS1 protein results in increased susceptibility to Nitric Oxide CTD PMID:25033204 NCBI chr 2:31,470,270...31,520,670
Ensembl chr 2:31,470,207...31,520,672
JBrowse link
G Atp1a1 ATPase, Na+/K+ transporting, alpha 1 polypeptide multiple interactions ISO Nitric Oxide deficiency inhibits the reaction [Clofibrate results in increased expression of ATP1A1 protein] CTD PMID:15018640 NCBI chr 3:101,576,219...101,604,707
Ensembl chr 3:101,576,219...101,604,684
JBrowse link
G Atp5b ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit increases expression EXP Nitric Oxide deficiency results in increased expression of ATP5B mRNA CTD PMID:15878706 NCBI chr10:128,083,307...128,090,388
Ensembl chr10:128,083,273...128,090,391
JBrowse link
G Avp arginine vasopressin affects metabolic processing
increases expression
multiple interactions
ISO AVP protein affects the metabolism of Nitric Oxide
Nitric Oxide results in increased expression of AVP mRNA
IL1B protein affects the reaction [AVP protein affects the metabolism of Nitric Oxide]
CTD PMID:10460269 PMID:21171372 NCBI chr 2:130,580,620...130,582,588
Ensembl chr 2:130,580,620...130,582,554
JBrowse link
G Axl AXL receptor tyrosine kinase decreases expression EXP Nitric Oxide deficiency results in decreased expression of AXL mRNA CTD PMID:15878706 NCBI chr 7:25,756,500...25,788,924
Ensembl chr 7:25,757,273...25,788,705
JBrowse link
G B2m beta-2 microglobulin increases expression ISO Nitric Oxide results in increased expression of B2M protein CTD PMID:15764486 NCBI chr 2:122,147,687...122,153,082
Ensembl chr 2:122,147,686...122,153,083
JBrowse link
G Bax BCL2-associated X protein affects localization
multiple interactions
decreases expression
EXP
ISO
Nitric Oxide affects the localization of BAX protein
Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in increased expression of and affects the localization of BAX protein]
[Nitroprusside results in increased abundance of Nitric Oxide] which affects the localization of BAX protein; SB 203580 inhibits the reaction [[Nitroprusside results in increased abundance of Nitric Oxide] which affects the localization of BAX protein]
Nitric Oxide results in decreased expression of BAX protein
[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased expression of BAX protein
CTD PMID:10828028 PMID:14634119 PMID:22878015 PMID:25726415 NCBI chr 7:45,461,695...45,466,903
Ensembl chr 7:45,461,697...45,466,898
JBrowse link
G Bbc3 BCL2 binding component 3 increases expression ISO Nitric Oxide results in increased expression of BBC3 mRNA CTD PMID:15126337 NCBI chr 7:16,308,398...16,318,334
Ensembl chr 7:16,308,393...16,318,205
JBrowse link
G Bcar1 breast cancer anti-estrogen resistance 1 multiple interactions
decreases phosphorylation
ISO Nitric Oxide inhibits the reaction [BCAR1 protein binds to CRK protein]
Nitric Oxide results in decreased phosphorylation of BCAR1 protein
CTD PMID:12714323 NCBI chr 8:111,710,474...111,743,849
Ensembl chr 8:111,710,474...111,743,809
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 decreases expression
affects expression
multiple interactions
ISO
EXP
Nitric Oxide results in decreased expression of BCL2 protein
Nitric Oxide affects the expression of BCL2 mRNA
[3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA]; [linsidomine results in increased abundance of Nitric Oxide] which results in increased expression of BCL2 mRNA; [linsidomine results in increased abundance of Nitric Oxide] which results in increased expression of BCL2 protein; [Quercetin results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitric Oxide results in increased nitrosation of and results in decreased degradation of BCL2 protein]; [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in decreased expression of BCL2 protein; Nitric Oxide results in increased nitrosation of and results in decreased degradation of BCL2 protein; pimagedine inhibits the reaction [Nitric Oxide results in increased nitrosation of and results in decreased degradation of BCL2 protein]
CTD PMID:7706495 PMID:10828028 PMID:15126337 PMID:16980304 PMID:17135264 NCBI chr 1:106,538,176...106,714,290
Ensembl chr 1:106,538,178...106,714,274
JBrowse link
G Bcl2l1 BCL2-like 1 decreases expression
increases expression
multiple interactions
ISO Nitric Oxide results in decreased expression of BCL2L1 protein
Nitric Oxide results in increased expression of BCL2L1 mRNA
GATA5 protein promotes the reaction [Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 mRNA]]; GATA5 protein promotes the reaction [Nitric Oxide results in increased expression of BCL2L1 mRNA]; Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 mRNA]; Nitric Oxide results in increased expression of and affects the localization of BCL2L1 protein
CTD PMID:15126337 PMID:25726415 NCBI chr 2:152,758,732...152,833,803
Ensembl chr 2:152,780,668...152,831,728
JBrowse link
G Bdkrb2 bradykinin receptor, beta 2 multiple interactions ISO [kallidin, des-Arg(10)- binds to and results in increased activity of BDKRB2 protein] which results in increased chemical synthesis of Nitric Oxide; [KNG1 protein modified form binds to and results in increased activity of BDKRB2 protein] which results in increased chemical synthesis of Nitric Oxide CTD PMID:29775649 NCBI chr12:105,563,172...105,595,244
Ensembl chr12:105,563,226...105,595,237
JBrowse link
G Bdnf brain derived neurotrophic factor increases chemical synthesis
multiple interactions
ISO BDNF protein results in increased chemical synthesis of Nitric Oxide
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [BDNF protein results in increased chemical synthesis of Nitric Oxide]
CTD PMID:17172126 NCBI chr 2:109,674,700...109,727,043
Ensembl chr 2:109,674,700...109,727,007
JBrowse link
G Bid BH3 interacting domain death agonist increases cleavage ISO Nitric Oxide results in increased cleavage of BID protein CTD PMID:15126337 NCBI chr 6:120,893,119...120,917,062
Ensembl chr 6:120,891,930...120,916,853
JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 increases expression EXP Nitric Oxide results in increased expression of BIRC2 protein CTD PMID:14634119 NCBI chr 9:7,818,226...7,837,131
Ensembl chr 9:7,818,227...7,837,064
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 increases expression
decreases expression
EXP
ISO
Nitric Oxide results in increased expression of BIRC3 protein
Nitric Oxide results in decreased expression of BIRC3 mRNA
CTD PMID:14634119 PMID:15126337 NCBI chr 9:7,847,468...7,873,205
Ensembl chr 9:7,848,699...7,873,186
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO
EXP
Nitric Oxide results in decreased expression of BIRC5 mRNA
Nitric Oxide results in decreased expression of BIRC5 protein
CTD PMID:15126337 PMID:16166326 NCBI chr11:117,849,237...117,855,743
Ensembl chr11:117,849,251...117,855,743
JBrowse link
G Bmp1 bone morphogenetic protein 1 decreases expression EXP Nitric Oxide deficiency results in decreased expression of BMP1 mRNA CTD PMID:15878706 NCBI chr14:70,474,555...70,520,716
Ensembl chr14:70,474,558...70,520,234
JBrowse link
G Bnip3 BCL2/adenovirus E1B interacting protein 3 increases expression
decreases expression
ISO
EXP
Nitric Oxide results in increased expression of BNIP3 protein
Nitric Oxide results in decreased expression of BNIP3 mRNA
CTD PMID:11592958 PMID:16002567 NCBI chr 7:138,890,836...138,909,506
Ensembl chr 7:138,890,836...138,909,519
JBrowse link
G Cacna1a calcium channel, voltage-dependent, P/Q type, alpha 1A subunit multiple interactions ISO CACNA1A protein affects the reaction [Potassium Chloride results in increased abundance of Nitric Oxide] CTD PMID:12770949 NCBI chr 8:84,338,631...84,640,251
Ensembl chr 8:84,338,639...84,640,246
JBrowse link
G Cacna1b calcium channel, voltage-dependent, N type, alpha 1B subunit multiple interactions ISO CACNA1B protein affects the reaction [Potassium Chloride results in increased abundance of Nitric Oxide] CTD PMID:12770949 NCBI chr 2:24,603,860...24,763,200
Ensembl chr 2:24,603,887...24,763,152
JBrowse link
G Calcrl calcitonin receptor-like increases expression ISO Nitric Oxide deficiency results in increased expression of CALCRL mRNA; Nitric Oxide deficiency results in increased expression of CALCRL protein CTD PMID:16326922 NCBI chr 2:84,330,626...84,425,405
Ensembl chr 2:84,330,626...84,425,411
JBrowse link
G Calm1 calmodulin 1 multiple interactions ISO [Calcium binds to CALM1 protein] promotes the reaction [NOS1 protein results in increased chemical synthesis of Nitric Oxide] CTD PMID:17098364 NCBI chr12:100,199,435...100,209,824
Ensembl chr12:100,199,435...100,209,814
JBrowse link
G Casp1 caspase 1 multiple interactions EXP [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased activity of and results in increased cleavage of CASP1 protein CTD PMID:10903723 NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
JBrowse link
G Casp3 caspase 3 multiple interactions
increases activity
increases metabolic processing
decreases activity
decreases cleavage
ISO
EXP
[NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]; [NOS2 protein results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein; [NOS2 protein results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of CASP3 protein]; [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein; [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein]; Dithiothreitol inhibits the reaction [Nitric Oxide results in decreased activity of CASP3 protein]; Nitric Oxide inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP3 protein]
Nitric Oxide results in increased activity of CASP3 protein
Nitric Oxide results in increased metabolism of CASP3 protein
[Nitric Oxide Donors results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein; Cyclic GMP affects the reaction [Nitric Oxide results in decreased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one inhibits the reaction [[Nitric Oxide Donors results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]]; Nitric Oxide affects the activity of and affects the cleavage of CASP3 protein; Nitric Oxide results in decreased cleavage of and results in decreased activity of CASP3 protein
[Nitric Oxide Donors results in increased abundance of Nitric Oxide] inhibits the reaction [[TNF protein co-treated with Galactosamine] results in increased activity of CASP3 protein]; [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP3 protein; SB 203580 inhibits the reaction [[Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP3 protein]; U 0126 inhibits the reaction [[Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP3 protein]
Nitric Oxide results in decreased cleavage of CASP3 protein
CTD PMID:9388267 PMID:9706149 PMID:9755104 PMID:10222263 PMID:10358093 PMID:10728388 PMID:10811113 PMID:10828028 PMID:12606818 PMID:14634119 PMID:15126337 PMID:20020783 PMID:20179380 PMID:22878015 NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
JBrowse link
G Casp7 caspase 7 decreases cleavage ISO Nitric Oxide results in decreased cleavage of CASP7 protein CTD PMID:10222263 NCBI chr19:56,396,833...56,442,348
Ensembl chr19:56,397,129...56,442,344
JBrowse link
G Casp8 caspase 8 multiple interactions
increases activity
ISO
EXP
Nitric Oxide results in decreased cleavage of and results in decreased activity of CASP8 protein
[Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP8 protein
Nitric Oxide results in increased activity of CASP8 protein
CTD PMID:10358093 PMID:15126337 PMID:22878015 NCBI chr 1:58,795,233...58,847,503
Ensembl chr 1:58,795,374...58,847,503
JBrowse link
G Casp9 caspase 9 decreases activity
multiple interactions
increases activity
EXP
ISO
Nitric Oxide results in decreased activity of CASP9 protein
[Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP9 protein
Nitric Oxide results in increased activity of CASP9 protein
CTD PMID:14634119 PMID:15126337 PMID:22878015 NCBI chr 4:141,793,612...141,815,978
Ensembl chr 4:141,793,612...141,815,976
JBrowse link
G Cat catalase multiple interactions ISO Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of CAT mRNA]; Nitric Oxide promotes the reaction [Sertraline inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]]; Nitric Oxide promotes the reaction [Venlafaxine Hydrochloride inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]] CTD PMID:20305041 PMID:21983654 NCBI chr 2:103,453,904...103,485,153
Ensembl chr 2:103,453,849...103,485,160
JBrowse link
G Cav1 caveolin 1, caveolae protein multiple interactions
increases expression
ISO [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide; Nitric Oxide results in decreased ubiquitination of and results in decreased degradation of CAV1 protein; Nitric Oxide results in increased metabolism of and results in increased stability of CAV1 protein
Nitric Oxide results in increased expression of CAV1 protein
CTD PMID:18296501 PMID:19706615 NCBI chr 6:17,306,335...17,341,328
Ensembl chr 6:17,306,335...17,341,452
JBrowse link
G Ccl5 chemokine (C-C motif) ligand 5 decreases secretion
multiple interactions
ISO
EXP
Nitric Oxide results in decreased secretion of CCL5 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide]; [CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide; Disulfiram inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide]; wortmannin inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide]
CTD PMID:13678430 PMID:19016906 NCBI chr11:83,525,778...83,530,518
Ensembl chr11:83,525,778...83,530,518
JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions EXP [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] which results in decreased expression of CCN2 protein CTD PMID:24412304 NCBI chr10:24,595,442...24,598,683
Ensembl chr10:24,595,442...24,598,683
JBrowse link
G Ccr5 chemokine (C-C motif) receptor 5 multiple interactions EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide]; [CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide; Disulfiram inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide]; wortmannin inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] CTD PMID:19016906 NCBI chr 9:124,121,543...124,127,183
Ensembl chr 9:124,121,543...124,147,699
JBrowse link
G Cd14 CD14 antigen multiple interactions ISO CD14 protein affects the reaction [G(M1) Ganglioside results in increased secretion of Nitric Oxide]; CD14 protein affects the reaction [ganglioside, GD1a results in increased secretion of Nitric Oxide]; CD14 protein affects the reaction [Gangliosides results in increased secretion of Nitric Oxide]; CD14 protein affects the reaction [Lipopolysaccharides results in increased secretion of Nitric Oxide]; CD14 protein affects the reaction [trisialoganglioside GT1 results in increased secretion of Nitric Oxide] CTD PMID:16651628 NCBI chr18:36,725,064...36,726,815
Ensembl chr18:36,725,067...36,726,798
JBrowse link
G Cd28 CD28 antigen multiple interactions
increases abundance
ISO 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [CD28 protein results in increased abundance of Nitric Oxide]; 2-aminoethoxydiphenylborane inhibits the reaction [CD28 protein results in increased abundance of Nitric Oxide]; 5-diisopropoxyphosphoryl-5-methyl-1-pyrroline-N-oxide inhibits the reaction [CD28 protein results in increased abundance of Nitric Oxide]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [CD28 protein results in increased abundance of Nitric Oxide] CTD PMID:14607919 NCBI chr 1:60,746,388...60,773,359
Ensembl chr 1:60,716,800...60,773,359
JBrowse link
G Cd86 CD86 antigen decreases expression ISO Nitric Oxide results in decreased expression of CD86 protein CTD PMID:13678430 NCBI chr16:36,568,956...36,666,158
Ensembl chr16:36,603,869...36,666,081
JBrowse link
G Cdh1 cadherin 1 decreases expression ISO Nitric Oxide results in decreased expression of CDH1 mRNA CTD PMID:20179380 NCBI chr 8:106,603,350...106,670,247
Ensembl chr 8:106,603,351...106,670,246
JBrowse link
G Cdx2 caudal type homeobox 2 increases chemical synthesis EXP CDX2 gene mutant form results in increased chemical synthesis of Nitric Oxide CTD PMID:29439001 NCBI chr 5:147,300,900...147,307,249
Ensembl chr 5:147,300,805...147,307,270
JBrowse link
G Cftr cystic fibrosis transmembrane conductance regulator multiple interactions ISO Nitric Oxide inhibits the reaction [CFTR protein promotes the reaction [Cyclic AMP results in increased transport of Chlorine]] CTD PMID:12612912 NCBI chr 6:18,170,687...18,322,770
Ensembl chr 6:18,170,687...18,322,768
JBrowse link
G Chrm1 cholinergic receptor, muscarinic 1, CNS multiple interactions ISO [(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride binds to CHRM1 protein] which results in increased abundance of Nitric Oxide; [muscarinic toxin 7 binds to and results in decreased activity of CHRM1 protein] inhibits the reaction [Amphetamine results in increased abundance of Nitric Oxide] CTD PMID:18991861 NCBI chr19:8,664,005...8,683,606
Ensembl chr19:8,663,789...8,683,587
JBrowse link
G Cnr1 cannabinoid receptor 1 (brain) multiple interactions EXP
ISO
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]; [anandamide binds to and results in increased activity of CNR1 protein] inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]; rimonabant inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [Lipopolysaccharides results in increased transport of Nitric Oxide]]; rimonabant inhibits the reaction [[anandamide binds to and results in increased activity of CNR1 protein] inhibits the reaction [Lipopolysaccharides results in increased transport of Nitric Oxide]]; SR 144528 inhibits the reaction [[anandamide binds to and results in increased activity of CNR1 protein] inhibits the reaction [Lipopolysaccharides results in increased transport of Nitric Oxide]]
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]; CNR1 protein affects the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in decreased abundance of Nitric Oxide]; rimonabant inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]]; rimonabant inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] which results in decreased abundance of Nitric Oxide]
CTD PMID:10027878 PMID:11727767 PMID:11891798 NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
JBrowse link
G Col1a2 collagen, type I, alpha 2 multiple interactions
increases expression
ISO Amlodipine inhibits the reaction [Nitric Oxide deficiency results in increased expression of COL1A2 mRNA] CTD PMID:10445667 NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
JBrowse link
G Col5a3 collagen, type V, alpha 3 decreases expression EXP Nitric Oxide deficiency results in decreased expression of COL5A3 mRNA CTD PMID:15878706 NCBI chr 9:20,770,050...20,815,117
Ensembl chr 9:20,770,050...20,815,067
JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4I1 increases expression EXP Nitric Oxide deficiency results in increased expression of COX4I1 mRNA CTD PMID:15878706 NCBI chr 8:120,668,225...120,674,209
Ensembl chr 8:120,668,222...120,674,207
JBrowse link
G Cpd carboxypeptidase D affects chemical synthesis
multiple interactions
ISO CPD affects the chemical synthesis of Nitric Oxide
[PRL results in increased expression of CPD mRNA] which results in increased chemical synthesis of Nitric Oxide; [Testosterone results in increased expression of CPD mRNA] which results in increased chemical synthesis of Nitric Oxide
CTD PMID:21688280 NCBI chr11:76,777,208...76,847,008
Ensembl chr11:76,778,424...76,847,018
JBrowse link
G Cps1 carbamoyl-phosphate synthetase 1 affects abundance ISO CPS1 gene SNP affects the abundance of Nitric Oxide metabolite CTD PMID:14718356 NCBI chr 1:67,122,426...67,231,267
Ensembl chr 1:67,123,026...67,231,259
JBrowse link
G Crh corticotropin releasing hormone multiple interactions
increases expression
ISO CRH protein affects the reaction [Nitric Oxide results in increased secretion of POMC protein alternative form]
Nitric Oxide results in increased expression of CRH mRNA
CTD PMID:10460269 NCBI chr 3:19,693,401...19,695,396
Ensembl chr 3:19,693,401...19,695,396
JBrowse link
G Crhr1 corticotropin releasing hormone receptor 1 increases expression ISO Nitric Oxide results in increased expression of CRHR1 mRNA CTD PMID:10460269 NCBI chr11:104,130,463...104,175,523
Ensembl chr11:104,132,855...104,175,523
JBrowse link
G Crk v-crk avian sarcoma virus CT10 oncogene homolog multiple interactions ISO Nitric Oxide inhibits the reaction [BCAR1 protein binds to CRK protein] CTD PMID:12714323 NCBI chr11:75,679,194...75,708,428
Ensembl chr11:75,679,259...75,706,908
JBrowse link
G Csf1 colony stimulating factor 1 (macrophage) multiple interactions
decreases activity
ISO
EXP
[CSF1 protein co-treated with CSF2 protein] promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide]; [Lipopolysaccharides co-treated with CSF1 protein] results in increased chemical synthesis of Nitric Oxide; Benzene promotes the reaction [[[Lipopolysaccharides co-treated with IFNG protein] co-treated with CSF1 protein] results in increased chemical synthesis of Nitric Oxide]; Benzene promotes the reaction [[Lipopolysaccharides co-treated with CSF1 protein] results in increased chemical synthesis of Nitric Oxide]; CSF1 protein promotes the reaction [IFNG protein results in increased chemical synthesis of Nitric Oxide]; CSF1 protein promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide]; Enzyme Inhibitors inhibits the reaction [CSF1 protein promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide]]; Enzyme Inhibitors inhibits the reaction [Nitric Oxide results in decreased activity of CSF1 protein]
[Benzene promotes the reaction [[CSF1 protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA]] which results in increased chemical synthesis of Nitric Oxide
CTD PMID:8193360 NCBI chr 3:107,741,048...107,760,469
Ensembl chr 3:107,741,048...107,760,469
JBrowse link
G Csf1r colony stimulating factor 1 receptor multiple interactions ISO [CSF1R protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide; Benzene promotes the reaction [[CSF1R protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; hydroquinone promotes the reaction [[CSF1R protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; hydroxyhydroquinone promotes the reaction [[CSF1R protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; quinone promotes the reaction [[CSF1R protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] CTD PMID:7884313 NCBI chr18:61,105,572...61,131,139
Ensembl chr18:61,100,598...61,132,149
JBrowse link
G Csf2 colony stimulating factor 2 (granulocyte-macrophage) multiple interactions ISO
EXP
[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide; CSF2 protein promotes the reaction [ITGB2 protein results in increased abundance of Nitric Oxide]; Ozone promotes the reaction [[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide]
[CSF1 protein co-treated with CSF2 protein] promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide]
[Benzene co-treated with Enzyme Inhibitors] promotes the reaction [[Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide]; [CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide; [Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide; Benzene promotes the reaction [[[Lipopolysaccharides co-treated with IFNG protein] co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide]; Benzene promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; Benzene promotes the reaction [[Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide]; hydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; hydroxyhydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; quinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]
CTD PMID:7884313 PMID:8193360 PMID:8600936 NCBI chr11:54,247,270...54,249,899
Ensembl chr11:54,247,271...54,249,667
JBrowse link
G Ctf1 cardiotrophin 1 increases chemical synthesis ISO CTF1 protein results in increased chemical synthesis of Nitric Oxide CTD PMID:11304496 NCBI chr 7:127,712,676...127,718,188
Ensembl chr 7:127,712,736...127,718,192
JBrowse link
G Cth cystathionase (cystathionine gamma-lyase) decreases expression ISO Nitric Oxide deficiency results in decreased expression of CTH mRNA CTD PMID:14508194 NCBI chr 3:157,894,248...157,925,081
Ensembl chr 3:157,894,248...157,925,077
JBrowse link
G Ctsd cathepsin D increases secretion ISO Nitric Oxide results in increased secretion of CTSD protein CTD PMID:15040013 NCBI chr 7:142,375,910...142,387,827
Ensembl chr 7:142,375,911...142,388,038
JBrowse link
G Cxcl10 chemokine (C-X-C motif) ligand 10 decreases secretion ISO Nitric Oxide results in decreased secretion of CXCL10 protein CTD PMID:13678430 NCBI chr 5:92,346,638...92,348,889
Ensembl chr 5:92,346,638...92,348,889
JBrowse link
G Cxcl12 chemokine (C-X-C motif) ligand 12 decreases expression EXP Nitric Oxide deficiency results in decreased expression of CXCL12 mRNA CTD PMID:15878706 NCBI chr 6:117,168,535...117,181,368
Ensembl chr 6:117,168,535...117,181,367
JBrowse link
G Cxcl15 chemokine (C-X-C motif) ligand 15 increases expression ISO Nitric Oxide results in increased expression of CXCL8 protein CTD PMID:10619828 NCBI chr 5:90,794,534...90,803,067
Ensembl chr 5:90,794,534...90,803,067
JBrowse link
G Cxcr4 chemokine (C-X-C motif) receptor 4 decreases expression EXP Nitric Oxide deficiency results in decreased expression of CXCR4 mRNA CTD PMID:15878706 NCBI chr 1:128,588,199...128,592,299
Ensembl chr 1:128,588,199...128,592,293
JBrowse link
G Cycs cytochrome c, somatic decreases secretion
affects localization
ISO Nitric Oxide results in decreased secretion of CYCS protein
Nitric Oxide affects the localization of CYCS protein
CTD PMID:10222263 PMID:10356289 PMID:10358093 PMID:16024610 NCBI chr 6:50,562,563...50,566,569
Ensembl chr 6:50,562,563...50,566,538
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions ISO [CYP2E1 protein results in increased metabolism of Ethanol] which results in increased abundance of Nitric Oxide CTD PMID:18845238 NCBI chr 7:140,763,819...140,774,990
Ensembl chr 7:140,763,739...140,774,987
JBrowse link
G Dab1 disabled 1 decreases expression EXP Nitric Oxide deficiency results in decreased expression of DAB1 mRNA CTD PMID:15878706 NCBI chr 4:103,619,500...104,744,844
Ensembl chr 4:103,619,359...104,744,844
JBrowse link
G Ddc dopa decarboxylase increases activity ISO Nitric Oxide deficiency results in increased activity of DDC protein CTD PMID:7541690 NCBI chr11:11,814,101...11,898,144
Ensembl chr11:11,814,101...11,898,144
JBrowse link
G Dffb DNA fragmentation factor, beta subunit increases activity ISO Nitric Oxide results in increased activity of DFFB protein CTD PMID:15040013 NCBI chr 4:153,964,447...153,975,121
Ensembl chr 4:153,964,449...153,975,126
JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein affects localization ISO Nitric Oxide affects the localization of DIABLO protein CTD PMID:15126337 NCBI chr 5:123,511,330...123,524,164
Ensembl chr 5:123,509,765...123,524,176
JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO Nitric Oxide results in increased expression of DUSP1 mRNA CTD PMID:9699677 NCBI chr17:26,505,591...26,508,472
Ensembl chr17:26,505,590...26,562,128
JBrowse link
G Ech1 enoyl coenzyme A hydratase 1, peroxisomal increases expression EXP Nitric Oxide deficiency results in increased expression of ECH1 mRNA CTD PMID:15878706 NCBI chr 7:28,825,338...28,832,239
Ensembl chr 7:28,825,217...28,832,247
JBrowse link
G Edn1 endothelin 1 increases chemical synthesis
increases secretion
decreases activity
increases expression
multiple interactions
increases abundance
decreases expression
ISO
EXP
EDN1 protein results in increased chemical synthesis of Nitric Oxide
Nitric Oxide results in increased secretion of EDN1 protein
Nitric Oxide deficiency results in decreased activity of EDN1 protein
Nitric Oxide deficiency results in increased expression of EDN1 mRNA
[EDN1 protein results in increased activity of EDNRB protein] which results in increased abundance of Nitric Oxide; [EDN1 protein results in increased activity of NOS1 protein] which results in increased abundance of Nitric Oxide; BQ 788 inhibits the reaction [EDN1 protein results in increased abundance of Nitric Oxide]; Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of EDN1 mRNA]; Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of EDN1 mRNA]; Nitric Oxide inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]; Nitric Oxide inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein]; S-methylthiocitrulline inhibits the reaction [EDN1 protein results in increased abundance of Nitric Oxide]
Nitric Oxide results in decreased expression of EDN1 protein
Nitric Oxide results in increased expression of EDN1 protein
Nitric Oxide results in increased expression of EDN1 mRNA
CTD PMID:11187978 PMID:15640287 PMID:15838368 PMID:16326922 PMID:16380457 PMID:16389725 PMID:16810074 PMID:20197249 PMID:20929026 NCBI chr13:42,301,476...42,307,990
Ensembl chr13:42,301,476...42,307,990
JBrowse link
G Ednrb endothelin receptor type B multiple interactions ISO [EDN1 protein results in increased activity of EDNRB protein] which results in increased abundance of Nitric Oxide CTD PMID:16380457 NCBI chr14:103,814,615...103,844,508
Ensembl chr14:103,814,625...103,844,402
JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 increases expression EXP Nitric Oxide deficiency results in increased expression of EEF1A1 mRNA CTD PMID:15878706 NCBI chr 9:78,478,453...78,481,724
Ensembl chr 9:78,478,449...78,489,151
JBrowse link
G Eef1b2 eukaryotic translation elongation factor 1 beta 2 increases expression EXP Nitric Oxide deficiency results in increased expression of EEF1B2 mRNA CTD PMID:15878706 NCBI chr 1:63,176,831...63,180,486
Ensembl chr 1:63,176,825...63,180,486
JBrowse link
G Ehmt2 euchromatic histone lysine N-methyltransferase 2 decreases expression ISO Nitric Oxide results in decreased expression of EHMT2 protein CTD PMID:23546878 NCBI chr17:34,898,463...34,914,073
Ensembl chr17:34,898,469...34,914,052
JBrowse link
G Eif1a eukaryotic translation initiation factor 1A decreases expression EXP Nitric Oxide deficiency results in decreased expression of EIF1A mRNA CTD PMID:15878706 NCBI chr18:46,597,704...46,610,225
Ensembl chr18:46,597,701...46,616,456
JBrowse link
G Eif2ak1 eukaryotic translation initiation factor 2 alpha kinase 1 multiple interactions EXP Nitric Oxide inhibits the reaction [Mercury results in decreased activity of EIF2AK1 protein] CTD PMID:17689536 NCBI chr 5:143,817,792...143,902,717
Ensembl chr 5:143,817,788...143,904,251
JBrowse link
G Eif2b4 eukaryotic translation initiation factor 2B, subunit 4 delta decreases expression EXP Nitric Oxide deficiency results in decreased expression of EIF2B4 mRNA CTD PMID:15878706 NCBI chr 5:31,187,558...31,193,139
Ensembl chr 5:31,187,558...31,193,430
JBrowse link
G Eif3g eukaryotic translation initiation factor 3, subunit G increases expression EXP Nitric Oxide deficiency results in increased expression of EIF3G mRNA CTD PMID:15878706 NCBI chr 9:20,894,349...20,898,590
Ensembl chr 9:20,894,349...20,898,623
JBrowse link
G Epas1 endothelial PAS domain protein 1 multiple interactions EXP EPAS1 protein affects the reaction [Cobalt results in increased abundance of Nitric Oxide]; EPAS1 protein affects the reaction [Nickel results in increased abundance of Nitric Oxide] CTD PMID:23788631 NCBI chr17:86,753,864...86,833,410
Ensembl chr17:86,753,700...86,833,410
JBrowse link
G Epo erythropoietin decreases response to substance ISO EPO protein results in decreased susceptibility to Nitric Oxide CTD PMID:15816862 NCBI chr 5:137,483,020...137,485,816
Ensembl chr 5:137,483,020...137,533,242
JBrowse link
G Esr1 estrogen receptor 1 (alpha) multiple interactions ISO [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide CTD PMID:18296501 NCBI chr10:4,611,989...5,005,633
Ensembl chr10:4,611,593...5,005,614
JBrowse link
G Ezh1 enhancer of zeste 1 polycomb repressive complex 2 subunit decreases expression EXP Nitric Oxide deficiency results in decreased expression of EZH1 mRNA CTD PMID:15878706 NCBI chr11:101,191,115...101,226,463
Ensembl chr11:101,191,115...101,226,463
JBrowse link
G Ezr ezrin increases phosphorylation ISO Nitric Oxide deficiency results in increased phosphorylation of EZR protein CTD PMID:14732730 NCBI chr17:6,738,131...6,782,780
Ensembl chr17:6,738,041...6,782,784
JBrowse link
G F2 coagulation factor II multiple interactions
increases abundance
ISO arsenite inhibits the reaction [F2 protein results in increased abundance of Nitric Oxide]; F2 protein promotes the reaction [Heparin results in increased abundance of Nitric Oxide] CTD PMID:8408661 PMID:22244921 NCBI chr 2:91,612,397...91,636,457
Ensembl chr 2:91,625,320...91,636,414
JBrowse link
G Fas Fas (TNF receptor superfamily member 6) increases expression ISO Nitric Oxide results in increased expression of FAS mRNA; Nitric Oxide results in increased expression of FAS protein CTD PMID:15126337 NCBI chr19:34,290,647...34,327,775
Ensembl chr19:34,290,666...34,327,772
JBrowse link
G Fasl Fas ligand (TNF superfamily, member 6) multiple interactions ISO [linsidomine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; [linsidomine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter]; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter]; [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter]; [spermine nitric oxide complex results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; [spermine nitric oxide complex results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter]; Nitric Oxide inhibits the reaction [Etoposide results in increased activity of FASLG promoter] CTD PMID:10811113 NCBI chr 1:161,780,691...161,788,495
Ensembl chr 1:161,780,689...161,788,495
JBrowse link
G Fgf1 fibroblast growth factor 1 increases abundance
multiple interactions
ISO FGF1 protein results in increased abundance of Nitric Oxide
PD 166866 inhibits the reaction [FGF1 protein results in increased abundance of Nitric Oxide]
CTD PMID:16524372 NCBI chr18:38,838,672...38,929,470
Ensembl chr18:38,838,673...38,929,472
JBrowse link
G Fosb FBJ osteosarcoma oncogene B increases activity ISO Nitric Oxide results in increased activity of FOSB protein CTD PMID:15949472 NCBI chr 7:19,302,696...19,310,118
Ensembl chr 7:19,302,696...19,310,051
JBrowse link
G Ftl1 ferritin light polypeptide 1 increases expression EXP Nitric Oxide deficiency results in increased expression of FTL1 mRNA CTD PMID:15878706 NCBI chr 7:45,457,944...45,459,886
Ensembl chr 7:45,457,944...45,459,884
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase multiple interactions
increases expression
ISO
EXP
[7-nitroindazole results in decreased chemical synthesis of Nitric Oxide] inhibits the reaction [Paraquat affects the localization of GAPDH protein]
Nitric Oxide deficiency results in increased expression of GAPDH mRNA
CTD PMID:15878706 PMID:20478973 NCBI chr 6:125,161,852...125,166,467
Ensembl chr 6:125,161,715...125,166,467
JBrowse link
G Gata5 GATA binding protein 5 multiple interactions
increases expression
increases response to substance
ISO GATA5 protein promotes the reaction [Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 mRNA]]; GATA5 protein promotes the reaction [Nitric Oxide results in increased expression of BCL2L1 mRNA]; Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of GATA5 mRNA]; Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of GATA5 protein]
Nitric Oxide results in increased expression of GATA5 mRNA; Nitric Oxide results in increased expression of GATA5 protein
GATA5 protein results in increased susceptibility to Nitric Oxide
CTD PMID:25726415 NCBI chr 2:180,325,088...180,335,503
Ensembl chr 2:180,325,133...180,334,699
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit decreases expression ISO Nitric Oxide deficiency results in decreased expression of GCLC mRNA; Nitric Oxide deficiency results in decreased expression of GCLC protein CTD PMID:19631198 NCBI chr 9:77,754,535...77,794,489
Ensembl chr 9:77,754,535...77,794,485
JBrowse link
G Gclm glutamate-cysteine ligase, modifier subunit multiple interactions ISO GCLM gene SNP affects the abundance of and affects the activity of and affects the susceptibility to Nitric Oxide CTD PMID:12975258 NCBI chr 3:122,245,487...122,267,215
Ensembl chr 3:122,245,557...122,270,732
JBrowse link
G Gdi2 guanosine diphosphate (GDP) dissociation inhibitor 2 decreases expression EXP Nitric Oxide deficiency results in decreased expression of GDI2 mRNA CTD PMID:15878706 NCBI chr13:3,538,075...3,566,261
Ensembl chr13:3,538,063...3,567,871
JBrowse link
G Gfap glial fibrillary acidic protein decreases expression ISO Nitric Oxide deficiency results in decreased expression of GFAP protein CTD PMID:15763998 NCBI chr11:102,887,336...102,897,200
Ensembl chr11:102,887,336...102,900,912
JBrowse link
G Gja1 gap junction protein, alpha 1 decreases expression ISO Nitric Oxide deficiency results in decreased expression of GJA1 mRNA; Nitric Oxide deficiency results in decreased expression of GJA1 protein; Nitric Oxide results in decreased expression of GJA1 protein CTD PMID:10397678 PMID:11856964 PMID:20004189 NCBI chr10:56,377,300...56,390,419
Ensembl chr10:56,377,330...56,402,513
JBrowse link
G Glb1 galactosidase, beta 1 decreases activity ISO Nitric Oxide results in decreased activity of GLB1 protein CTD PMID:17075048 NCBI chr 9:114,401,078...114,474,379
Ensembl chr 9:114,401,076...114,474,898
JBrowse link
G Gltp glycolipid transfer protein increases expression EXP Nitric Oxide deficiency results in increased expression of GLTP mRNA CTD PMID:15878706 NCBI chr 5:114,669,490...114,690,935
Ensembl chr 5:114,669,398...114,690,984
JBrowse link
G Gm20348 predicted gene, 20348 increases expression ISO Nitric Oxide results in increased expression of TP53I3 mRNA CTD PMID:15126337 NCBI chr12:4,810,475...4,817,155 JBrowse link
G Gpc1 glypican 1 increases nitrosation
multiple interactions
EXP Nitric Oxide results in increased nitrosation of GPC1 protein
[Ascorbic Acid co-treated with Nitric Oxide] results in increased degradation of GPC1 protein modified form; Zinc promotes the reaction [[Ascorbic Acid co-treated with Nitric Oxide] results in increased degradation of GPC1 protein modified form]
CTD PMID:15677459 PMID:16923158 NCBI chr 1:92,831,645...92,860,211
Ensembl chr 1:92,831,645...92,860,779
JBrowse link
G Gpi1 glucose-6-phosphate isomerase 1 increases expression EXP Nitric Oxide deficiency results in increased expression of GPI1 mRNA CTD PMID:15878706 NCBI chr 7:34,201,327...34,230,336
Ensembl chr 7:34,201,330...34,230,336
JBrowse link
G Gpx1 glutathione peroxidase 1 affects metabolic processing
multiple interactions
EXP GPX1 protein affects the metabolism of Nitric Oxide
GPX1 protein affects the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide]
CTD PMID:11498278 NCBI chr 9:108,339,080...108,340,342
Ensembl chr 9:108,338,903...108,340,343
JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression EXP Nitric Oxide deficiency results in increased expression of GPX2 mRNA CTD PMID:15878706 NCBI chr12:76,792,335...76,795,554
Ensembl chr12:76,792,333...76,795,554
JBrowse link
G Gpx3 glutathione peroxidase 3 increases expression
multiple interactions
EXP
ISO
Nitric Oxide deficiency results in increased expression of GPX3 mRNA
Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of GPX3 mRNA]
CTD PMID:15878706 PMID:21983654 NCBI chr11:54,902,854...54,910,387
Ensembl chr11:54,902,453...54,910,377
JBrowse link
G Grb2 growth factor receptor bound protein 2 decreases expression EXP Nitric Oxide deficiency results in decreased expression of GRB2 mRNA CTD PMID:15878706 NCBI chr11:115,644,045...115,708,597
Ensembl chr11:115,644,045...115,708,597
JBrowse link
G Gsn gelsolin increases expression EXP Nitric Oxide deficiency results in increased expression of GSN mRNA CTD PMID:15878706 NCBI chr 2:35,256,359...35,307,902
Ensembl chr 2:35,256,380...35,307,892
JBrowse link
G Gsr glutathione reductase increases expression
multiple interactions
affects activity
ISO Nitric Oxide deficiency results in increased expression of GSR protein
tempol inhibits the reaction [Nitric Oxide deficiency results in increased expression of GSR protein]
Nitric Oxide deficiency affects the activity of GSR protein
CTD PMID:15925750 PMID:19631198 NCBI chr 8:33,653,238...33,698,162
Ensembl chr 8:33,652,523...33,698,163
JBrowse link
G Gstm1 glutathione S-transferase, mu 1 increases expression EXP Nitric Oxide deficiency results in increased expression of GSTM1 mRNA CTD PMID:15878706 NCBI chr 3:108,012,250...108,017,973
Ensembl chr 3:108,012,255...108,017,973
JBrowse link
G Gstm2 glutathione S-transferase, mu 2 increases expression EXP Nitric Oxide deficiency results in increased expression of GSTM2 mRNA CTD PMID:15878706 NCBI chr 3:107,981,702...107,986,420
Ensembl chr 3:107,981,702...107,986,453
JBrowse link
G Gucy1a1 guanylate cyclase 1, soluble, alpha 1 multiple interactions
increases response to substance
ISO 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one affects the folding of [Nitric Oxide binds to [GUCY1A1 protein binds to GUCY1B1 protein]]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole affects the folding of [Nitric Oxide binds to [GUCY1A1 protein binds to GUCY1B1 protein]]
GUCY1A1 gene mutant form results in increased susceptibility to Nitric Oxide
CTD PMID:11744065 PMID:25373139 NCBI chr 3:82,092,427...82,145,946
Ensembl chr 3:82,092,427...82,145,789
JBrowse link
G Gucy1b1 guanylate cyclase 1, soluble, beta 1 multiple interactions ISO 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one affects the folding of [Nitric Oxide binds to [GUCY1A1 protein binds to GUCY1B1 protein]]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole affects the folding of [Nitric Oxide binds to [GUCY1A1 protein binds to GUCY1B1 protein]] CTD PMID:11744065 NCBI chr 3:82,032,004...82,074,711
Ensembl chr 3:82,032,006...82,074,689
JBrowse link
G Gulo gulonolactone (L-) oxidase multiple interactions EXP [GULO protein co-treated with NOS3 protein] results in increased abundance of Nitric Oxide CTD PMID:16737683 NCBI chr14:65,986,786...66,009,254
Ensembl chr14:65,986,786...66,009,207
JBrowse link
G H2-Eb1 histocompatibility 2, class II antigen E beta increases abundance ISO HLA-DRB1 protein results in increased abundance of Nitric Oxide CTD PMID:17075829 NCBI chr17:34,305,867...34,316,674
Ensembl chr17:34,305,867...34,316,674
JBrowse link
G Hadh hydroxyacyl-Coenzyme A dehydrogenase increases expression EXP Nitric Oxide deficiency results in increased expression of HADH mRNA CTD PMID:15878706 NCBI chr 3:131,233,419...131,272,101
Ensembl chr 3:131,233,419...131,272,101
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 increases expression ISO Nitric Oxide deficiency results in increased expression of HAVCR1 protein CTD PMID:19834340 NCBI chr11:46,739,822...46,779,578
Ensembl chr11:46,735,080...46,779,578
JBrowse link
G Hbs1l Hbs1-like (S. cerevisiae) decreases expression EXP Nitric Oxide deficiency results in decreased expression of HBS1L mRNA CTD PMID:15878706 NCBI chr10:21,295,979...21,368,889
Ensembl chr10:21,295,979...21,368,898
JBrowse link
G Hcrt hypocretin increases abundance ISO HCRT results in increased abundance of Nitric Oxide CTD PMID:18378017 NCBI chr11:100,761,693...100,762,931
Ensembl chr11:100,761,069...100,762,931
JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit multiple interactions ISO Nitric Oxide results in decreased stability of and results in decreased expression of HIF1A protein; U 0126 inhibits the reaction [Nitric Oxide results in decreased degradation of and results in increased activity of HIF1A protein] CTD PMID:16310922 PMID:18424783 NCBI chr12:73,901,324...73,947,554
Ensembl chr12:73,901,375...73,947,530
JBrowse link
G Hmox1 heme oxygenase 1 decreases response to substance
increases expression
affects activity
multiple interactions
affects response to substance
ISO
EXP
HMOX1 protein results in decreased susceptibility to Nitric Oxide
Nitric Oxide results in increased expression of HMOX1 protein
Nitric Oxide affects the activity of HMOX1 protein
Nitric Oxide results in increased expression of HMOX1 mRNA; Nitric Oxide results in increased expression of HMOX1 protein
HMOX1 protein promotes the reaction [[Raloxifene Hydrochloride results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide]; Nitric Oxide results in increased stability of and results in increased expression of HMOX1 mRNA
HMOX1 protein affects the susceptibility to Nitric Oxide
CTD PMID:9699677 PMID:15220209 PMID:17020887 PMID:17401437 PMID:18178725 PMID:19183270 PMID:20888885 PMID:21690482 NCBI chr 8:75,093,618...75,100,593
Ensembl chr 8:75,093,621...75,100,589
JBrowse link
G Hprt hypoxanthine guanine phosphoribosyl transferase increases mutagenesis ISO Nitric Oxide results in increased mutagenesis of HPRT1 gene CTD PMID:22303861 PMID:28454271 NCBI chr  X:52,988,078...53,021,660
Ensembl chr  X:52,988,137...53,021,659
JBrowse link
G Hspa5 heat shock protein 5 multiple interactions ISO [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in decreased expression of HSPA5 mRNA; [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in decreased expression of HSPA5 protein CTD PMID:19320461 NCBI chr 2:34,772,090...34,776,529
Ensembl chr 2:34,771,970...34,777,547
JBrowse link
G Hspa8 heat shock protein 8 multiple interactions ISO [sodium arsenite results in increased expression of HSPA8 protein] which results in decreased chemical synthesis of Nitric Oxide CTD PMID:10216529 NCBI chr 9:40,801,276...40,805,202
Ensembl chr 9:40,800,984...40,810,087
JBrowse link
G Hyal2 hyaluronoglucosaminidase 2 decreases expression EXP Nitric Oxide deficiency results in decreased expression of HYAL2 mRNA CTD PMID:15878706 NCBI chr 9:107,567,873...107,572,778
Ensembl chr 9:107,567,945...107,572,779
JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO Nitric Oxide deficiency inhibits the reaction [nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased expression of ICAM1 protein]] CTD PMID:14762100 NCBI chr 9:21,015,940...21,028,814
Ensembl chr 9:21,015,985...21,028,817
JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 multiple interactions ISO Nitric Oxide binds to and affects the folding of and results in increased degradation of and results in decreased activity of IDO1 protein CTD PMID:16834326 NCBI chr 8:24,584,133...24,596,952
Ensembl chr 8:24,584,136...24,597,009
JBrowse link
G Ifnb1 interferon beta 1, fibroblast multiple interactions EXP [IFNB1 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide; Dexamethasone inhibits the reaction [[IFNB1 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; Quercetin inhibits the reaction [[IFNB1 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; tocotrienol, delta inhibits the reaction [[IFNB1 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] CTD PMID:22185406 NCBI chr 4:88,522,025...88,522,794
Ensembl chr 4:88,522,025...88,522,774
JBrowse link
G Ifng interferon gamma increases secretion
increases chemical synthesis
multiple interactions
increases abundance
ISO
EXP
Nitric Oxide results in increased secretion of IFNG protein
IFNG protein results in increased chemical synthesis of Nitric Oxide
1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide]; [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] which results in decreased expression of CCN2 protein; [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide; [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [[TNF protein co-treated with IFNG protein] affects the expression of NOS2 mRNA] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [[TNF protein co-treated with IFNG protein] affects the expression of NOS2 protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [IFNG protein co-treated with hydroxyhydroquinone] results in increased abundance of Nitric Oxide; [IFNG protein co-treated with Lipopolysaccharides co-treated with quinone] results in increased abundance of Nitric Oxide; [IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide; [IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide; [IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein; [IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG] results in increased abundance of Nitric Oxide; [Lipopolysaccharides co-treated with TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide; [TNF co-treated with IL1B co-treated with IFNG] results in increased abundance of Nitric Oxide; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide; [TNF protein co-treated with IFNG protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide; [TNF protein co-treated with IFNG protein] results in increased secretion of Nitric Oxide; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; Aminosalicylic Acids inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; aristolochic acid I inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Benzene promotes the reaction [[[Lipopolysaccharides co-treated with IFNG protein] co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide]; Benzene promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; Benzene promotes the reaction [IFNG protein results in increased chemical synthesis of Nitric Oxide]; Capsaicin inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; Capsaicin inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; capsazepine inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; capsazepine inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; catalpol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; chromous chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; ciglitazone inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; cobaltiprotoporphyrin inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; cobaltous chloride promotes the reaction [[[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; cupric chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Dexamethasone inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; Dexamethasone inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; Diquat promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide]; Ditiocarb inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide]; Dronabinol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG] results in increased abundance of Nitric Oxide]; Estriol inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; Genistein inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; Glyburide inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; GPX1 protein affects the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide]; GW 1929 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Ibuprofen inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; IFNG promotes the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]; IFNG protein inhibits the reaction [Cyclophosphamide results in increased abundance of Nitric Oxide]; IFNG protein promotes the reaction [[Lipopolysaccharides co-treated with Benzene] results in increased abundance of Nitric Oxide]; IFNG protein promotes the reaction [[Lipopolysaccharides co-treated with hydroquinone] results in increased abundance of Nitric Oxide]; IFNG protein promotes the reaction [[Lipopolysaccharides co-treated with hydroxyhydroquinone] results in increased abundance of Nitric Oxide]; IFNG protein promotes the reaction [Lipopolysaccharides results in increased secretion of Nitric Oxide]; IL4 protein inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; Indomethacin inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; JAK2 protein promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide]; lead chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; lead chloride inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; Lipopolysaccharides promotes the reaction [[IFNG protein co-treated with hydroxyhydroquinone] results in increased abundance of Nitric Oxide]; Lipopolysaccharides promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide]; manganese chloride promotes the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; manganese chloride promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]; Manganese promotes the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Manganese promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]; Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; MK 473 inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide]; NFKBIA protein affects the reaction [manganese chloride promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]]; NFKBIA protein affects the reaction [Manganese promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]]; nickel chloride promotes the reaction [[[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] affects the localization of Zinc]; Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT1 mRNA]; Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT2 mRNA]; NOS2 protein promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; NOS2 protein promotes the reaction [cobaltous chloride promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]]; NOS2 protein promotes the reaction [nickel chloride promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]]; NS 1652 inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide]; NS3728 inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide]; peroxyvanadate inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]]; peroxyvanadate promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide]; pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide]; pimagedine inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; pimagedine inhibits the reaction [Lipopolysaccharides promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide]]; PPARG protein affects the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Progesterone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; Quercetin inhibits the reaction [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; Quercetin inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; resiniferatoxin inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; resiniferatoxin inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; Resveratrol inhibits the reaction [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; Resveratrol inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; sodium arsenite inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Sulfasalazine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Tamoxifen inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide]; TBE 31 inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; tocotrienol, delta inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; U 0126 inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; wogonin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; zinc chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]
[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide; [IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [IL5 protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of Nitric Oxide; [NOS2 protein results in increased abundance of Nitric Oxide] affects the susceptibility to [IL1B protein co-treated with TNF protein co-treated with IFNG protein]; Benzene promotes the reaction [[[Lipopolysaccharides co-treated with IFNG protein] co-treated with CSF1 protein] results in increased chemical synthesis of Nitric Oxide]; Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Clofibrate inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; CSF1 protein promotes the reaction [IFNG protein results in increased chemical synthesis of Nitric Oxide]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide]; Ditiocarb inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of Nitric Oxide]; Gemfibrozil inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; morin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of Nitric Oxide]; pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; wortmannin inhibits the reaction [Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]]
IFNG protein results in increased abundance of Nitric Oxide; IFNG results in increased abundance of Nitric Oxide
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]]; [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]; [IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased abundance of Nitric Oxide; [IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide; [IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide; [IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG protein co-treated with Manganese] results in decreased abundance of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [pyrazolanthrone co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; [SB 203580 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; [TNF co-treated with IL1B co-treated with IFNG] results in increased abundance of Nitric Oxide; [TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [U 0126 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Chenodeoxycholic Acid inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Deoxycholic Acid inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; IFNG promotes the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]; IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]; Indomethacin inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Manganese inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Nitric Oxide affects the susceptibility to [IFNG protein co-treated with Lipopolysaccharides]; Ozone promotes the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; Ozone promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide]; pimagedine inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; Polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; pyrazolanthrone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; Rimonabant inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]]; S-methylisothiopseudouronium inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; SB 203580 inhibits the reaction [[IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased abundance of Nitric Oxide]; SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]; SB 203580 inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; U 0126 inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Ursodeoxycholic Acid inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]
CTD PMID:7519435 PMID:7689037 PMID:7884313 PMID:8193360 PMID:8341679 PMID:8765472 PMID:8903404 PMID:8975779 PMID:8979148 PMID:10205001 PMID:10607705 PMID:10909967 PMID:11020457 PMID:11063824 PMID:11080519 PMID:11282106 PMID:11498278 PMID:11529938 PMID:11727767 PMID:11907163 PMID:12244038 PMID:12612912 PMID:12620498 PMID:12847270 PMID:12911628 PMID:13678430 PMID:14530214 PMID:14617770 PMID:14623498 PMID:15177305 PMID:16168523 PMID:16307444 PMID:16366677 PMID:16488514 PMID:16968468 PMID:18090225 PMID:18206661 PMID:19393675 PMID:19446535 PMID:19825429 PMID:20424383 PMID:21361338 PMID:21943492 PMID:22185406 PMID:22461696 PMID:22698256 PMID:23164921 PMID:23362215 PMID:24412304 PMID:25766886 PMID:28242320 NCBI chr10:118,441,046...118,445,894
Ensembl chr10:118,441,046...118,445,892
JBrowse link
G Il10 interleukin 10 decreases secretion ISO Nitric Oxide results in decreased secretion of IL10 protein CTD PMID:13678430 NCBI chr 1:131,019,845...131,024,970
Ensembl chr 1:131,019,845...131,024,974
JBrowse link
G Il12b interleukin 12b decreases expression ISO Nitric Oxide results in decreased expression of IL12B protein CTD PMID:13678430 NCBI chr11:44,400,063...44,414,677
Ensembl chr11:44,400,063...44,414,033
JBrowse link
G Il12rb2 interleukin 12 receptor, beta 2 increases expression EXP Nitric Oxide results in increased expression of IL12RB2 mRNA CTD PMID:12451176 NCBI chr 6:67,285,986...67,376,293
Ensembl chr 6:67,291,318...67,376,188
JBrowse link
G Il1a interleukin 1 alpha multiple interactions
increases abundance
ISO [IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; wortmannin inhibits the reaction [Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]]
geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in increased abundance of Nitric Oxide]]; Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in increased abundance of Nitric Oxide]]; Simvastatin inhibits the reaction [IL1A results in increased abundance of Nitric Oxide]; Y 27632 inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in increased abundance of Nitric Oxide]]
CTD PMID:15705589 PMID:16968468 NCBI chr 2:129,299,609...129,310,186
Ensembl chr 2:129,299,610...129,309,972
JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases chemical synthesis
increases abundance
ISO
EXP
15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; [IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide; [IL1B protein co-treated with Fatty Acids, Nonesterified] results in increased chemical synthesis of Nitric Oxide; [IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased abundance of Nitric Oxide; [NOS2 protein results in increased abundance of Nitric Oxide] affects the susceptibility to [IL1B protein co-treated with TNF protein co-treated with IFNG protein]; Asbestos, Crocidolite promotes the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Asbestos, Serpentine promotes the reaction [IL1B protein results in increased abundance of Nitric Oxide]; bisphenol A inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Clofibrate inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Cytochalasin B inhibits the reaction [Asbestos, Crocidolite promotes the reaction [IL1B protein results in increased abundance of Nitric Oxide]]; Cytochalasin B inhibits the reaction [Asbestos, Serpentine promotes the reaction [IL1B protein results in increased abundance of Nitric Oxide]]; Dactinomycin inhibits the reaction [IL1B results in increased abundance of Nitric Oxide]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide]; Estradiol inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Gemfibrozil inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Glucosamine analog affects the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Glucosamine inhibits the reaction [IL1B results in increased abundance of Nitric Oxide]; Gold Sodium Thiomalate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Hydroxychloroquine inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; IL1B protein promotes the reaction [NOS2 protein results in increased abundance of Nitric Oxide]; IL4 protein inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Leflunomide inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; LEP protein affects the reaction [IL1B protein results in increased chemical synthesis of Nitric Oxide]; Methotrexate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Nitric Oxide deficiency inhibits the reaction [nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased expression of ICAM1 protein]]; Nitric Oxide deficiency inhibits the reaction [nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased expression of SELE protein]]; nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased abundance of Nitric Oxide]; pimagedine inhibits the reaction [Asbestos, Crocidolite promotes the reaction [IL1B protein results in increased abundance of Nitric Oxide]]; pimagedine inhibits the reaction [Asbestos, Serpentine promotes the reaction [IL1B protein results in increased abundance of Nitric Oxide]]; sauchinone inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; sodium arsenite inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Triglycerides affects the reaction [IL1B protein results in increased chemical synthesis of Nitric Oxide]; Troglitazone inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Troglitazone inhibits the reaction [IL1B protein results in increased chemical synthesis of Nitric Oxide]
[TNF co-treated with IL1B co-treated with IFNG] results in increased abundance of Nitric Oxide; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide; IL1B protein promotes the reaction [Cobalt results in increased abundance of Nitric Oxide]; IL1B protein promotes the reaction [Nickel results in increased abundance of Nitric Oxide]; Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] affects the localization of Zinc]; Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT1 mRNA]; Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT2 mRNA]
IL1B protein results in increased abundance of Nitric Oxide; IL1B results in increased abundance of Nitric Oxide
[Enzyme Inhibitors results in decreased abundance of Nitric Oxide] inhibits the reaction [IL1B protein results in decreased secretion of INS1 protein]; [IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide; [IL1B protein results in increased expression of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [IL1B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [TNF co-treated with IL1B co-treated with IFNG] results in increased abundance of Nitric Oxide; Active Hexose Correlated Compound inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; Active Hexose Correlated Compound inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Adenosine inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Edaravone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Glucosamine inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; IL1B protein affects the reaction [AVP protein affects the metabolism of Nitric Oxide]; Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Ozone promotes the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; Ozone promotes the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Rotenone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; SOD2 protein inhibits the reaction [IL1B protein results in increased chemical synthesis of Nitric Oxide]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]
CTD PMID:7519435 PMID:8903404 PMID:8982730 PMID:9312173 PMID:9576743 PMID:9698594 PMID:10365824 PMID:10909967 PMID:11229466 PMID:11286988 PMID:11457450 PMID:11530235 PMID:12115740 PMID:12244038 PMID:12384474 PMID:14617770 PMID:14623498 PMID:14762100 PMID:14996425 PMID:15144122 PMID:15223066 PMID:16393772 PMID:16492401 PMID:17109745 PMID:17712145 PMID:18026701 PMID:18078833 PMID:18090225 PMID:19347386 PMID:19393675 PMID:20600708 PMID:21171372 PMID:21943492 PMID:23788631 PMID:24425765 PMID:24878381 PMID:25766886 PMID:29356224 NCBI chr 2:129,364,569...129,371,164
Ensembl chr 2:129,364,570...129,371,139
JBrowse link
G Il4 interleukin 4 multiple interactions ISO
EXP
IL4 protein inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]
IL4 protein inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]
CTD PMID:12115740 PMID:12612912 NCBI chr11:53,612,460...53,618,665
Ensembl chr11:53,602,982...53,618,669
JBrowse link
G Il5 interleukin 5 multiple interactions
decreases secretion
ISO [IL5 protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide
Nitric Oxide results in decreased secretion of IL5 protein
CTD PMID:13678430 PMID:18206661 NCBI chr11:53,720,794...53,725,103
Ensembl chr11:53,720,794...53,725,106
JBrowse link
G Il6 interleukin 6 multiple interactions EXP
ISO
Plant Extracts inhibits the reaction [[Lipopolysaccharides results in increased expression of IL6 protein] which results in increased chemical synthesis of Nitric Oxide]
Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of IL6 protein]
CTD PMID:20708382 PMID:21983654 NCBI chr 5:30,013,114...30,019,975
Ensembl chr 5:30,013,114...30,019,981
JBrowse link
G Ins2 insulin II increases secretion
decreases secretion
multiple interactions
increases chemical synthesis
ISO INS protein results in increased secretion of Nitric Oxide
INS protein results in decreased secretion of Nitric Oxide
[INS protein co-treated with Glucose] results in decreased chemical synthesis of Nitric Oxide; [Orotic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] which results in decreased abundance of Nitric Oxide; Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]; Kynurenic Acid inhibits the reaction [[INS protein co-treated with Glucose] results in decreased chemical synthesis of Nitric Oxide]; Orotic Acid inhibits the reaction [INS protein results in increased abundance of Nitric Oxide]; Palmitates inhibits the reaction [INS protein results in increased chemical synthesis of Nitric Oxide]; PIK3CA protein inhibits the reaction [[Orotic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] which results in decreased abundance of Nitric Oxide]; quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased chemical synthesis of Nitric Oxide]]; Quercetin inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased chemical synthesis of Nitric Oxide]]; resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]; SIRT1 protein affects the reaction [INS protein results in increased secretion of Nitric Oxide]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]]; Sodium Salicylate inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased chemical synthesis of Nitric Oxide]]
CTD PMID:20960276 PMID:23504962 PMID:25601987 PMID:26364587 PMID:28951307 NCBI chr 7:142,678,656...142,679,726
Ensembl chr 7:142,678,656...142,743,381
JBrowse link
G Itgb2 integrin beta 2 multiple interactions
increases abundance
ISO Nitric Oxide promotes the reaction [ITGB2 protein results in increased activity of RAP1A protein]; Nitric Oxide promotes the reaction [ITGB2 protein results in increased activity of RAP2A protein]
ITGB2 protein results in increased abundance of Nitric Oxide
[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide; [ITGB2 protein results in increased susceptibility to Ozone] which results in increased abundance of Nitric Oxide; CSF2 protein promotes the reaction [ITGB2 protein results in increased abundance of Nitric Oxide]; Ozone promotes the reaction [[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide]
CTD PMID:8600936 PMID:16963453 NCBI chr10:77,530,329...77,565,708
Ensembl chr10:77,530,252...77,565,708
JBrowse link
G Itgb3 integrin beta 3 increases expression ISO Nitric Oxide results in increased expression of ITGB3 protein CTD PMID:21332719 NCBI chr11:104,608,000...104,670,476
Ensembl chr11:104,608,000...104,670,476
JBrowse link
G Jak1 Janus kinase 1 decreases expression EXP Nitric Oxide deficiency results in decreased expression of JAK1 mRNA CTD PMID:15878706 NCBI chr 4:101,151,974...101,265,282
Ensembl chr 4:101,152,367...101,265,282
JBrowse link
G Jak2 Janus kinase 2 multiple interactions
decreases expression
EXP JAK2 protein promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide]
Nitric Oxide deficiency results in decreased expression of JAK2 mRNA
CTD PMID:12847270 PMID:15878706 NCBI chr19:29,251,803...29,313,095
Ensembl chr19:29,251,828...29,313,080
JBrowse link
G Jun jun proto-oncogene increases activity ISO Nitric Oxide results in increased activity of JUN protein CTD PMID:15949472 NCBI chr 4:95,049,036...95,052,222
Ensembl chr 4:95,049,034...95,052,222
JBrowse link
G Junb jun B proto-oncogene increases activity ISO Nitric Oxide results in increased activity of JUNB protein CTD PMID:15949472 NCBI chr 8:84,976,909...84,978,748
Ensembl chr 8:84,974,484...84,978,718
Ensembl chr 8:84,974,484...84,978,718
JBrowse link
G Kdm1a lysine (K)-specific demethylase 1A increases expression ISO Nitric Oxide results in increased expression of KDM1A mRNA CTD PMID:23546878 NCBI chr 4:136,550,533...136,602,787
Ensembl chr 4:136,550,540...136,602,723
JBrowse link
G Kdm3a lysine (K)-specific demethylase 3A increases expression ISO Nitric Oxide results in increased expression of KDM3A mRNA; Nitric Oxide results in increased expression of KDM3A protein CTD PMID:23546878 NCBI chr 6:71,588,970...71,632,990
Ensembl chr 6:71,588,972...71,632,990
JBrowse link
G Kdm3b KDM3B lysine (K)-specific demethylase 3B increases expression ISO Nitric Oxide results in increased expression of KDM3B mRNA CTD PMID:23546878 NCBI chr18:34,777,008...34,839,370
Ensembl chr18:34,777,047...34,838,660
JBrowse link
G Kdm4a lysine (K)-specific demethylase 4A increases expression ISO Nitric Oxide results in increased expression of KDM4A mRNA CTD PMID:23546878 NCBI chr 4:118,136,957...118,180,090
Ensembl chr 4:118,136,957...118,180,043
JBrowse link
G Kdm4b lysine (K)-specific demethylase 4B increases expression ISO Nitric Oxide results in increased expression of KDM4B mRNA CTD PMID:23546878 NCBI chr17:56,325,970...56,403,774
Ensembl chr17:56,326,062...56,402,870
JBrowse link
G Kdm4c lysine (K)-specific demethylase 4C increases expression ISO Nitric Oxide results in increased expression of KDM4C mRNA CTD PMID:23546878 NCBI chr 4:74,242,497...74,405,864
Ensembl chr 4:74,242,497...74,405,860
JBrowse link
G Kdm4d lysine (K)-specific demethylase 4D increases expression ISO Nitric Oxide results in increased expression of KDM4D mRNA CTD PMID:23546878 NCBI chr 9:14,462,548...14,500,522
Ensembl chr 9:14,462,548...14,500,482
JBrowse link
G Kdm7a lysine (K)-specific demethylase 7A increases expression ISO Nitric Oxide results in increased expression of KDM7A mRNA CTD PMID:23546878 NCBI chr 6:39,136,620...39,206,773
Ensembl chr 6:39,136,623...39,206,789
JBrowse link
G Klk1 kallikrein 1 increases abundance
multiple interactions
ISO KLK1 protein results in increased abundance of Nitric Oxide
icatibant inhibits the reaction [KLK1 protein results in increased abundance of Nitric Oxide]; KLK1 protein inhibits the reaction [Gentamicins results in decreased abundance of Nitric Oxide]
CTD PMID:16401625 NCBI chr 7:44,225,360...44,229,622
Ensembl chr 7:44,225,360...44,229,618
JBrowse link
G Kng2 kininogen 2 increases abundance
multiple interactions
increases secretion
affects abundance
ISO
EXP
KNG1 protein results in increased abundance of Nitric Oxide
[KNG1 protein modified form binds to and results in increased activity of BDKRB2 protein] which results in increased chemical synthesis of Nitric Oxide; Lipopolysaccharides promotes the reaction [KNG1 protein modified form results in increased chemical synthesis of Nitric Oxide]
KNG1 protein results in increased secretion of Nitric Oxide
KNG1 affects the abundance of Nitric Oxide
PD 123319 affects the reaction [KNG1 affects the abundance of Nitric Oxide]
CTD PMID:10535458 PMID:16514058 PMID:16733097 PMID:29775649 NCBI chr16:22,985,852...23,029,101
Ensembl chr16:22,985,854...23,029,482
JBrowse link
G Lep leptin multiple interactions ISO LEP protein affects the reaction [IL1B protein results in increased chemical synthesis of Nitric Oxide] CTD PMID:9312173 NCBI chr 6:29,060,221...29,073,876
Ensembl chr 6:29,060,220...29,073,877
JBrowse link
G Lif leukemia inhibitory factor multiple interactions EXP LIF protein affects the reaction [Progesterone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased abundance of Nitric Oxide]]; LIF protein inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased abundance of Nitric Oxide] CTD PMID:23409146 NCBI chr11:4,257,568...4,272,514
Ensembl chr11:4,257,557...4,272,514
JBrowse link
G Ltf lactotransferrin increases chemical synthesis
decreases activity
ISO LTF protein results in increased chemical synthesis of Nitric Oxide
Nitric Oxide deficiency results in decreased activity of LTF protein
CTD PMID:14563657 NCBI chr 9:111,019,292...111,042,766
Ensembl chr 9:111,019,271...111,042,767
JBrowse link
G Mapk1 mitogen-activated protein kinase 1 multiple interactions
decreases phosphorylation
decreases expression
ISO Nitric Oxide affects the reaction [Ditiocarb results in increased phosphorylation of MAPK1 protein]; Nitric Oxide affects the reaction [NGF protein results in increased activity of MAPK1 protein]; Nitric Oxide inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]
Nitric Oxide results in decreased phosphorylation of MAPK1 protein
Nitric Oxide results in decreased expression of MAPK1 protein
CTD PMID:14713289 PMID:15640287 PMID:16389725 PMID:16575906 PMID:16603213 NCBI chr16:16,983,382...17,047,453
Ensembl chr16:16,983,382...17,047,453
JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions
decreases phosphorylation
decreases expression
ISO Nitric Oxide affects the reaction [Ditiocarb results in increased phosphorylation of MAPK3 protein]; Nitric Oxide affects the reaction [NGF protein results in increased activity of MAPK3 protein]; Nitric Oxide inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein]
Nitric Oxide results in decreased phosphorylation of MAPK3 protein
Nitric Oxide results in decreased expression of MAPK3 protein
CTD PMID:14713289 PMID:15640287 PMID:16389725 PMID:16575906 PMID:16603213 NCBI chr 7:126,759,626...126,765,816
Ensembl chr 7:126,759,601...126,765,819
JBrowse link
G Mbp myelin basic protein increases abundance
multiple interactions
ISO MBP protein results in increased abundance of Nitric Oxide
Testosterone inhibits the reaction [MBP protein results in increased abundance of Nitric Oxide]
CTD PMID:18579221 NCBI chr18:82,475,091...82,585,637
Ensembl chr18:82,475,146...82,585,637
JBrowse link
G Mef2a myocyte enhancer factor 2A decreases expression EXP Nitric Oxide deficiency results in decreased expression of MEF2A mRNA CTD PMID:15878706 NCBI chr 7:67,231,163...67,376,456
Ensembl chr 7:67,231,163...67,372,858
JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 multiple interactions ISO [1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein; [S-nitrosocysteine results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein; [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein; Dithiothreitol inhibits the reaction [[1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [[S-nitrosocysteine results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein] CTD PMID:16386761 NCBI chr 6:138,140,527...138,156,755
Ensembl chr 6:138,140,316...138,156,755
JBrowse link
G Mmp2 matrix metallopeptidase 2 decreases expression
multiple interactions
ISO Nitric Oxide results in decreased expression of MMP2 protein
Nitric Oxide results in increased expression of and results in increased activity of MMP2 protein
CTD PMID:16575906 PMID:18796497 NCBI chr 8:92,827,290...92,853,421
Ensembl chr 8:92,827,291...92,853,420
JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression EXP Nitric Oxide results in increased expression of MMP9 mRNA CTD PMID:20197249 NCBI chr 2:164,940,326...164,955,850
Ensembl chr 2:164,940,780...164,955,850
JBrowse link
G Mpo myeloperoxidase increases expression
multiple interactions
ISO Nitric Oxide results in increased expression of MPO protein
[Paraquat co-treated with Nitric Oxide] results in increased activity of MPO protein
CTD PMID:10706834 PMID:15820443 NCBI chr11:87,793,784...87,804,412
Ensembl chr11:87,793,581...87,804,413
JBrowse link
G Mrps7 mitchondrial ribosomal protein S7 decreases expression EXP Nitric Oxide deficiency results in decreased expression of MRPS7 mRNA CTD PMID:15878706 NCBI chr11:115,604,140...115,608,036
Ensembl chr11:115,603,925...115,608,036
JBrowse link
G Msn moesin increases phosphorylation ISO Nitric Oxide deficiency results in increased phosphorylation of MSN protein CTD PMID:14732730 NCBI chr  X:96,096,045...96,168,553
Ensembl chr  X:96,096,042...96,168,552
JBrowse link
G mt-Co1 cytochrome c oxidase I, mitochondrial affects activity
affects expression
ISO Nitric Oxide affects the activity of COX1 protein
Nitric Oxide affects the expression of COX1 mRNA
CTD PMID:17936468 NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
JBrowse link
G Mt1 metallothionein 1 multiple interactions EXP Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT1 mRNA] CTD PMID:14617770 NCBI chr 8:94,178,883...94,180,327
Ensembl chr 8:94,179,082...94,180,327
JBrowse link
G Mt2 metallothionein 2 multiple interactions EXP Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT2 mRNA] CTD PMID:14617770 NCBI chr 8:94,172,618...94,173,567
Ensembl chr 8:94,172,664...94,173,568
JBrowse link
G Mt3 metallothionein 3 decreases response to substance ISO MT3 protein results in decreased susceptibility to Nitric Oxide CTD PMID:10854270 NCBI chr 8:94,152,607...94,154,148
Ensembl chr 8:94,152,607...94,154,146
JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions EXP [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]] CTD PMID:22363816 NCBI chr 4:148,448,582...148,557,685
Ensembl chr 4:148,448,611...148,557,683
JBrowse link
G Myh6 myosin, heavy polypeptide 6, cardiac muscle, alpha decreases expression ISO Nitric Oxide deficiency results in decreased expression of MYH6 mRNA CTD PMID:16326922 NCBI chr14:54,941,921...54,968,017
Ensembl chr14:54,941,921...54,966,927
JBrowse link
G Myh7 myosin, heavy polypeptide 7, cardiac muscle, beta increases expression
multiple interactions
ISO Nitric Oxide deficiency results in increased expression of MYH7 mRNA
Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of MYH7 mRNA]; Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of MYH7 mRNA]
CTD PMID:16326922 NCBI chr14:54,970,684...54,994,626
Ensembl chr14:54,970,684...54,994,626
JBrowse link
G Ndn necdin, MAGE family member decreases expression EXP Nitric Oxide deficiency results in decreased expression of NDN mRNA CTD PMID:15878706 NCBI chr 7:62,348,277...62,349,928
Ensembl chr 7:62,346,569...62,350,262
JBrowse link
G Ndrg1 N-myc downstream regulated gene 1 increases expression ISO Nitric Oxide results in increased expression of NDRG1 mRNA; Nitric Oxide results in increased expression of NDRG1 protein CTD PMID:21976667 NCBI chr15:66,929,318...66,969,641
Ensembl chr15:66,929,318...66,969,640
JBrowse link
G Ndufa13 NADH:ubiquinone oxidoreductase subunit A13 increases expression EXP Nitric Oxide deficiency results in increased expression of NDUFA13 mRNA CTD PMID:15878706 NCBI chr 8:69,894,163...69,902,558
Ensembl chr 8:69,894,180...69,902,558
JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 multiple interactions EXP NFKB1 protein promotes the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] CTD PMID:12162464 NCBI chr 3:135,584,655...135,691,969
Ensembl chr 3:135,584,655...135,691,547
JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha multiple interactions EXP NFKBIA protein affects the reaction [manganese chloride promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]]; NFKBIA protein affects the reaction [Manganese promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]] CTD PMID:16168523 NCBI chr12:55,489,409...55,492,647
Ensembl chr12:55,489,410...55,492,647
JBrowse link
G Ngf nerve growth factor multiple interactions ISO Nitric Oxide affects the reaction [NGF protein results in increased activity of MAPK1 protein]; Nitric Oxide affects the reaction [NGF protein results in increased activity of MAPK3 protein] CTD PMID:14713289 NCBI chr 3:102,469,919...102,521,013
Ensembl chr 3:102,469,919...102,521,013
JBrowse link
G Nos1 nitric oxide synthase 1, neuronal multiple interactions
increases chemical synthesis
decreases expression
EXP
ISO
PLAT protein affects the reaction [NOS1 protein results in increased chemical synthesis of Nitric Oxide]
Nitric Oxide deficiency results in decreased expression of NOS1 protein
[Calcium binds to CALM1 protein] promotes the reaction [NOS1 protein results in increased chemical synthesis of Nitric Oxide]; [Cisplatin results in increased expression of NOS1 mRNA] which results in increased abundance of Nitric Oxide; [EDN1 protein results in increased activity of NOS1 protein] which results in increased abundance of Nitric Oxide; [Formaldehyde results in increased expression of NOS1 protein] which results in increased abundance of Nitric Oxide; [NOS1 protein results in increased reduction of Trinitrotoluene] which results in decreased chemical synthesis of Nitric Oxide
CTD PMID:15223068 PMID:15249212 PMID:16380457 PMID:17098364 PMID:18195371 PMID:19038279 PMID:23359814 PMID:24184442 PMID:25766886 NCBI chr 5:117,866,839...117,958,840
Ensembl chr 5:117,781,032...117,958,840
JBrowse link
G Nos2 nitric oxide synthase 2, inducible increases abundance
affects abundance
increases chemical synthesis
decreases expression
affects expression
multiple interactions
increases expression
ISO
EXP
NOS2 protein results in increased abundance of Nitric Oxide
NOS2 promoter polymorphism affects the abundance of Nitric Oxide
NOS2 protein results in increased chemical synthesis of Nitric Oxide
Nitric Oxide deficiency results in decreased expression of NOS2 protein
Nitric Oxide deficiency affects the expression of NOS2 protein
[Endotoxins results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Ethanol results in decreased expression of and results in decreased activity of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [Formaldehyde results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [Fructose results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Gentamicins results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [IL1B protein results in increased expression of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [IL1B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Indomethacin results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Isoproterenol results in increased expression of NOS2] which results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides results in increased expression of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [NOS2 protein results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein; [NOS2 protein results in increased chemical synthesis of Nitric Oxide] which results in decreased susceptibility to endothelium-dependent hyperpolarization factor; [notoginsenoside R1 results in increased phosphorylation of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [S100B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [Taurocholic Acid results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; Active Hexose Correlated Compound inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; Edaravone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Endotoxins inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; natakalim inhibits the reaction [[Isoproterenol results in increased expression of NOS2] which results in increased chemical synthesis of Nitric Oxide]; Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of NOS2 mRNA]; NOS2 protein affects the reaction [Adenosine Triphosphate results in increased abundance of Nitric Oxide]; Ozone promotes the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; Ozone promotes the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Resveratrol inhibits the reaction [[Taurocholic Acid results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; Rotenone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; wuzi yanzong analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]
1,2-naphthoquinone inhibits the reaction [[lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; 3-methylquercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA]; [5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]] which results in decreased abundance of Nitric Oxide; [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] which results in decreased expression of CCN2 protein; [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide; [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [[TNF protein co-treated with IFNG protein] affects the expression of NOS2 mRNA] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [[TNF protein co-treated with IFNG protein] affects the expression of NOS2 protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [[TNF protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] which results in decreased expression of RETN mRNA; [Acetaminophen results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [Aspirin results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [Benzene promotes the reaction [[CSF1 protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA]] which results in increased chemical synthesis of Nitric Oxide; [Cisplatin results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [cobaltous chloride results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Deferoxamine results in increased expression of NOS2 mRNA] which results in increased abundance of Nitric Oxide; [diferuloylputrescine results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [ferulic acid results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein; [IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein; [Lipopolysaccharides results in increased expression of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased abundance of Nitric Oxide; [Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides results in increased expression of NOS2] which results in increased abundance of Nitric Oxide; [Lipopolysaccharides results in increased expression of NOS2] which results in increased chemical synthesis of Nitric Oxide; [Mycoplasma arthritidis mitogen results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Nicotine results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide; [Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [NOS2 protein results in increased chemical synthesis of Nitric Oxide] which results in decreased expression of TJP1 mRNA; [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [pimobendan results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide; [Plant Extracts results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [prunetin results in decreased expression of NOS2 mRNA] inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased chemical synthesis of Nitric Oxide]; [Putrescine metabolite results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [Quercetin results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA]; [S100B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]] which results in decreased chemical synthesis of Nitric Oxide; [Sodium Salicylate results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [Thiourea analog results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [TNF protein co-treated with IFNG protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [TNF protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [TNF protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [trans-3-(4'-hydroxyphenyl)-2-propenoic acid results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [Zoledronic Acid results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; Arsenic Trioxide inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Bee Venoms inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Bee Venoms inhibits the reaction [[TNF protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; bepafant inhibits the reaction [[Mycoplasma arthritidis mitogen results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; bisphenol A inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; Caffeine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; Capsaicin inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; Capsaicin inhibits the reaction [[Lipopolysaccharides results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; capsazepine inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; capsazepine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; Carthamus yellow inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Chalcone analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2] which results in increased abundance of Nitric Oxide]; chromous chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; ciglitazone inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Cilostazol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; cobaltiprotoporphyrin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; cobaltous chloride promotes the reaction [[[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; cupric chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Cyclosporine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; diphenylmethyl selenocyanate inhibits the reaction [[Cisplatin results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Drugs, Chinese Herbal inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate inhibits the reaction [Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of and results in increased abundance of Nitric Oxide]]; ethyl N-allyl-N-(2-methyl-3-(4-(4-amidinophenoxycarbonyl)phenyl)propenoyl)aminoacetate methanesulfonate inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; flavokawain A inhibits the reaction [Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Fluoxetine analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Ginkgo biloba extract inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; GW 1929 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; hinokiresinol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; lead chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of and results in increased abundance of Nitric Oxide]; Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; manganese chloride promotes the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Manganese promotes the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Melitten inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Melitten inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Melitten inhibits the reaction [[TNF protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; naringenin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; NFKB1 protein promotes the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; nickel chloride promotes the reaction [[[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; nimesulide inhibits the reaction [bepafant inhibits the reaction [[Mycoplasma arthritidis mitogen results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]]; Nitroprusside inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; NOS2 protein promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; NOS2 protein promotes the reaction [cobaltous chloride promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]]; NOS2 protein promotes the reaction [nickel chloride promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]]; NOS2 protein results in increased chemical synthesis of and results in increased abundance of Nitric Oxide; Plant Extracts inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; PPARG protein affects the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; praeruptorin A inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Pyrazines inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; pyrazolanthrone inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; pyrazolanthrone inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; pyrazolanthrone inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Quercetin analog inhibits the reaction [Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Quercetin inhibits the reaction [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Quercetin inhibits the reaction [Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; quercetin pentaacetate inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; resiniferatoxin inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; resiniferatoxin inhibits the reaction [[Lipopolysaccharides results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; Resveratrol inhibits the reaction [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased abundance of Nitric Oxide]; Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Resveratrol inhibits the reaction [Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Resveratrol metabolite inhibits the reaction [Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Rutin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; SB 203580 inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; SB 203580 inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; STAT1 protein promotes the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Tacrolimus inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; timosaponin BIII inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; zinc chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]
[[Fluvastatin results in increased expression of NOS2] which results in increased abundance of Nitric Oxide] which results in decreased expression of TFRC; [[Particulate Matter results in increased abundance of Ammonium Compounds] which results in decreased methylation of NOS2 promoter] which results in increased abundance of Nitric Oxide; [[Particulate Matter results in increased abundance of Carbon] which results in decreased methylation of NOS2 promoter] which results in increased abundance of Nitric Oxide; [[Particulate Matter results in increased abundance of Nitrates] which results in decreased methylation of NOS2 promoter] which results in increased abundance of Nitric Oxide; [Acetaldehyde results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [Ethanol results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [Fluvastatin results in increased expression of NOS2] which results in increased abundance of Nitric Oxide; [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [Fluvastatin results in increased abundance of Nitric Oxide]; [Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [NOS2 protein results in increased abundance of Nitric Oxide] affects the susceptibility to [IL1B protein co-treated with TNF protein co-treated with IFNG protein]; [NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]; [NOS2 protein results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein; [NOS2 protein results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein; [Raloxifene Hydrochloride results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; [Resveratrol results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide; [Trichloroethylene results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [Vehicle Emissions results in increased abundance of Air Pollutants] inhibits the reaction [NOS2 promoter polymorphism affects the abundance of Nitric Oxide]; Bee Venoms inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Cyclosporine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein]; Gold Sodium Thiomalate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; HMOX1 protein promotes the reaction [[Raloxifene Hydrochloride results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide]; Hydroxychloroquine inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; IL1B protein promotes the reaction [NOS2 protein results in increased abundance of Nitric Oxide]; Leflunomide inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; lornoxicam inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; Melitten inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Melitten inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Methotrexate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Nicotine promotes the reaction [NOS2 protein results in increased abundance of Nitric Oxide]; Peptides inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; pyrazolanthrone inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; pyrazolanthrone inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Tacrolimus inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; XDH protein promotes the reaction [[Raloxifene Hydrochloride results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide]
Nitric Oxide results in increased expression of NOS2 mRNA; Nitric Oxide results in increased expression of NOS2 protein
CTD PMID:7519435 PMID:7705308 PMID:8193360 PMID:8652180 PMID:8975779 PMID:8982730 PMID:9288130 PMID:9530173 PMID:9706149 PMID:9743513 PMID:9755104 PMID:9788894 PMID:10022268 PMID:10086329 PMID:10090849 PMID:10188978 PMID:10193745 PMID:10450786 PMID:10860828 PMID:10909967 PMID:11020457 PMID:11173986 PMID:11286988 PMID:11500931 PMID:11518563 PMID:11530235 PMID:11919077 PMID:12060119 PMID:12133974 PMID:12144947 PMID:12162464 PMID:12175900 PMID:12612912 PMID:12847270 PMID:12860292 PMID:14530214 PMID:15242784 PMID:15249212 PMID:15364003 PMID:15529353 PMID:16168523 PMID:16376947 PMID:16389574 PMID:16393772 PMID:16927020 PMID:16944022 PMID:17067557 PMID:17135264 PMID:17135361 PMID:17312373 PMID:17448908 PMID:17467989 PMID:17541474 PMID:17570326 PMID:17630198 PMID:17651055 PMID:17712145 PMID:17719164 PMID:18073202 PMID:18078833 PMID:18369347 PMID:18481332 PMID:18507870 PMID:18550010 PMID:18796497 PMID:18838107 PMID:18845238 PMID:19631198 PMID:19818098 PMID:20004183 PMID:20023007 PMID:20035746 PMID:20417174 PMID:20527891 PMID:20558268 PMID:20708382 PMID:20712904 PMID:20842678 PMID:20848677 PMID:20888885 PMID:20942565 PMID:20955790 PMID:21139339 PMID:21256160 PMID:21284090 PMID:21464294 PMID:21467642 PMID:21893401 PMID:21926162 PMID:21983654 PMID:22076046 PMID:22101131 PMID:22155221 PMID:22224493 PMID:22227475 PMID:22251620 PMID:22342441 PMID:22366099 PMID:22472292 PMID:22974838 PMID:23106696 PMID:23359814 PMID:23597450 PMID:23727179 PMID:23774260 PMID:24161485 PMID:24412304 PMID:24964743 PMID:25766886 PMID:25870319 PMID:26045775 PMID:26372312 PMID:26714306 PMID:27174236 PMID:30322157 NCBI chr11:78,920,787...78,960,226
Ensembl chr11:78,920,787...78,960,254
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell decreases chemical synthesis
multiple interactions
increases chemical synthesis
affects chemical synthesis
decreases expression
affects expression
increases abundance
ISO
EXP
NOS3 gene mutant form results in decreased chemical synthesis of Nitric Oxide
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased abundance of Nitric Oxide]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]]; [[resveratrol results in increased activity of PPARA protein] which results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide; [Estradiol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide; [Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide; [Glycochenodeoxycholic Acid results in decreased expression of NOS3 protein] which results in decreased abundance of Nitric Oxide; [Hydrogen Peroxide results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide; [Hydrogen Peroxide results in decreased expression of NOS3 protein] which results in decreased secretion of Nitric Oxide; [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which affects the expression of RCN1 protein; [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which affects the expression of TXNDC5 protein; [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in decreased expression of HSPA5 mRNA; [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in decreased expression of HSPA5 protein; [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in increased expression of SOD2 mRNA; [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in increased expression of SOD2 protein; [Orotic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] which results in decreased abundance of Nitric Oxide; [Orotic Acid inhibits the reaction [Metformin results in increased phosphorylation of NOS3 protein]] which results in decreased abundance of Nitric Oxide; [puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide; [resveratrol results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide; [resveratrol results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide; [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased abundance of Nitric Oxide; [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide; [Trichloroethylene results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide; Amiodarone promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]; desethylamiodarone promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]; fulvestrant inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; icariin promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]; Nifedipine inhibits the reaction [[Hydrogen Peroxide results in decreased expression of NOS3 protein] which results in decreased secretion of Nitric Oxide]; Nifedipine promotes the reaction [Simvastatin inhibits the reaction [[Hydrogen Peroxide results in decreased expression of NOS3 protein] which results in decreased secretion of Nitric Oxide]]; NOX5 protein promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]; PIK3CA protein inhibits the reaction [[Orotic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] which results in decreased abundance of Nitric Oxide]; resveratrol inhibits the reaction [[Hydrogen Peroxide results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide]; rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; Simvastatin inhibits the reaction [[Hydrogen Peroxide results in decreased expression of NOS3 protein] which results in decreased secretion of Nitric Oxide]; Simvastatin promotes the reaction [Nifedipine inhibits the reaction [[Hydrogen Peroxide results in decreased expression of NOS3 protein] which results in decreased secretion of Nitric Oxide]]; SOD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein]; Stilbenes inhibits the reaction [[Hydrogen Peroxide results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide]; Tretinoin promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]; U 0126 inhibits the reaction [[resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased abundance of Nitric Oxide]; W 7 inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; wortmannin inhibits the reaction [rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]]
NOS3 protein affects the chemical synthesis of Nitric Oxide
[Bezafibrate results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide; [GULO protein co-treated with NOS3 protein] results in increased abundance of Nitric Oxide; [Resveratrol results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide; dorsomorphin inhibits the reaction [[Bezafibrate results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]
Nitric Oxide deficiency results in decreased expression of NOS3 mRNA; Nitric Oxide deficiency results in decreased expression of NOS3 protein
Nitric Oxide deficiency affects the expression of NOS3 protein
[Sildenafil Citrate results in increased expression of NOS3 protein] which results in increased secretion of Nitric Oxide; AGT protein alternative form promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]; Enalapril inhibits the reaction [Nitric Oxide deficiency results in decreased expression of NOS3 protein]; Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in decreased expression of NOS3 protein]; Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of NOS3 mRNA]; Thioacetamide promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]
NOS3 protein results in increased abundance of Nitric Oxide
CTD PMID:10445667 PMID:11740345 PMID:12270858 PMID:12489993 PMID:15207323 PMID:15249212 PMID:16043647 PMID:16197366 PMID:16479044 PMID:16737683 PMID:17499557 PMID:17719164 PMID:18296501 PMID:18556569 PMID:18716157 PMID:18990443 PMID:19011239 PMID:19320461 PMID:19631198 PMID:19696404 PMID:19767878 PMID:19845545 PMID:20020783 PMID:20562903 PMID:20675566 PMID:21499286 PMID:21791144 PMID:21884717 PMID:21983654 PMID:22314268 PMID:22358095 PMID:24184442 PMID:25601987 NCBI chr 5:24,364,816...24,384,474
Ensembl chr 5:24,364,810...24,384,474
JBrowse link
G Npc1 NPC intracellular cholesterol transporter 1 decreases expression EXP Nitric Oxide deficiency results in decreased expression of NPC1 mRNA CTD PMID:15878706 NCBI chr18:12,189,694...12,236,506
Ensembl chr18:12,189,692...12,236,400
JBrowse link
G Nppa natriuretic peptide type A multiple interactions
increases expression
ISO Losartan inhibits the reaction [Nitric Oxide deficiency results in increased expression of NPPA mRNA]
Nitric Oxide deficiency results in increased expression of NPPA mRNA; Nitric Oxide deficiency results in increased expression of NPPA protein
CTD PMID:10397678 PMID:12198334 PMID:14700747 PMID:15177930 NCBI chr 4:148,000,722...148,002,074
Ensembl chr 4:148,000,722...148,002,079
JBrowse link
G Nppb natriuretic peptide type B multiple interactions
increases expression
ISO Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of NPPB mRNA]; Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of NPPB mRNA]; Losartan inhibits the reaction [Nitric Oxide deficiency results in increased expression of NPPB mRNA]
Nitric Oxide deficiency results in increased expression of NPPB mRNA; Nitric Oxide deficiency results in increased expression of NPPB protein
CTD PMID:12198334 PMID:16326922 NCBI chr 4:147,985,786...147,987,205
Ensembl chr 4:147,985,788...147,987,205
JBrowse link
G Nr2f2 nuclear receptor subfamily 2, group F, member 2 decreases expression EXP Nitric Oxide deficiency results in decreased expression of NR2F2 mRNA CTD PMID:15878706 NCBI chr 7:70,351,946...70,366,746
Ensembl chr 7:70,351,944...70,366,735
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions ISO [ginsenoside Re results in increased activity of NR3C1 protein] which results in increased abundance of Nitric Oxide CTD PMID:17490654 NCBI chr18:39,410,545...39,519,421
Ensembl chr18:39,410,545...39,519,421
JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 increases expression ISO Nitric Oxide results in increased expression of NR4A1 mRNA CTD PMID:10460269 NCBI chr15:101,253,902...101,274,795
Ensembl chr15:101,254,269...101,274,795
JBrowse link
G Nupr1 nuclear protein transcription regulator 1 decreases expression EXP Nitric Oxide deficiency results in decreased expression of NUPR1 mRNA CTD PMID:15878706 NCBI chr 7:126,623,246...126,625,470
Ensembl chr 7:126,623,249...126,630,861
JBrowse link
G Ocln occludin decreases expression ISO Nitric Oxide deficiency results in decreased expression of OCLN protein CTD PMID:15763998 NCBI chr13:100,496,504...100,552,718
Ensembl chr13:100,496,507...100,552,718
JBrowse link
G P4ha1 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide decreases expression EXP Nitric Oxide deficiency results in decreased expression of P4HA1 mRNA CTD PMID:15878706 NCBI chr10:59,323,197...59,373,304
Ensembl chr10:59,323,296...59,373,304
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 multiple interactions
increases cleavage
ISO
EXP
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]
PARP1 gene mutant form inhibits the reaction [S100B protein results in increased secretion of Nitric Oxide]
Nitric Oxide results in increased cleavage of PARP1 protein
CTD PMID:10811113 PMID:15126337 PMID:16024610 PMID:27444121 NCBI chr 1:180,568,891...180,600,999
Ensembl chr 1:180,568,924...180,601,254
JBrowse link
G Pdcd6ip programmed cell death 6 interacting protein decreases expression EXP Nitric Oxide deficiency results in decreased expression of PDCD6IP mRNA CTD PMID:15878706 NCBI chr 9:113,651,744...113,708,279
Ensembl chr 9:113,651,744...113,708,259
JBrowse link
G Pde5a phosphodiesterase 5A, cGMP-specific increases expression
affects response to substance
ISO Nitric Oxide results in increased expression of PDE5A mRNA; Nitric Oxide results in increased expression of PDE5A protein
PDE5A protein affects the susceptibility to Nitric Oxide
CTD PMID:19374906 NCBI chr 3:122,729,158...122,859,374
Ensembl chr 3:122,728,947...122,859,374
JBrowse link
G Phf8 PHD finger protein 8 increases expression ISO Nitric Oxide results in increased expression of PHF8 mRNA CTD PMID:23546878 NCBI chr  X:151,520,641...151,633,859
Ensembl chr  X:151,520,672...151,633,859
JBrowse link
G Pik3ca phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha multiple interactions ISO PIK3CA protein inhibits the reaction [[Orotic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] which results in decreased abundance of Nitric Oxide] CTD PMID:25601987 NCBI chr 3:32,397,065...32,466,112
Ensembl chr 3:32,397,671...32,468,486
JBrowse link
G Pla2g4a phospholipase A2, group IVA (cytosolic, calcium-dependent) multiple interactions ISO Nitric Oxide affects the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA]; Nitric Oxide affects the reaction [Ditiocarb results in increased expression of PLA2G4A protein] CTD PMID:16603213 NCBI chr 1:149,829,618...149,961,290
Ensembl chr 1:149,829,618...149,961,290
JBrowse link
G Plat plasminogen activator, tissue multiple interactions
increases secretion
EXP PLAT protein affects the reaction [NOS1 protein results in increased chemical synthesis of Nitric Oxide]
PLAT protein results in increased secretion of Nitric Oxide
CTD PMID:18195371 NCBI chr 8:22,757,722...22,782,848
Ensembl chr 8:22,757,727...22,782,844
JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression ISO Nitric Oxide results in increased expression of PMAIP1 mRNA CTD PMID:15126337 NCBI chr18:66,458,604...66,465,558
Ensembl chr18:66,458,533...66,465,565
JBrowse link
G Pms2 PMS1 homolog2, mismatch repair system component increases expression EXP Nitric Oxide deficiency results in increased expression of PMS2 mRNA CTD PMID:15878706 NCBI chr 5:143,909,901...143,972,745
Ensembl chr 5:143,909,964...143,933,968
JBrowse link
G Pnoc prepronociceptin decreases activity ISO Nitric Oxide deficiency results in decreased activity of PNOC protein CTD PMID:10794074 NCBI chr14:65,400,673...65,425,564
Ensembl chr14:65,400,673...65,425,472
JBrowse link
G Pomc pro-opiomelanocortin-alpha multiple interactions
decreases abundance
increases secretion
ISO CRH protein affects the reaction [Nitric Oxide results in increased secretion of POMC protein alternative form]
POMC protein results in decreased abundance of Nitric Oxide
CTD PMID:10460269 PMID:11193135 PMID:11703388 NCBI chr12:3,954,945...3,960,643
Ensembl chr12:3,954,951...3,960,642
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha affects activity
multiple interactions
increases expression
ISO Nitric Oxide affects the activity of PPARA protein
[[resveratrol results in increased activity of PPARA protein] which results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide
[Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased abundance of Nitric Oxide; [Clofibrate binds to and results in increased activity of PPARA protein] which results in increased abundance of Nitric Oxide; Nitric Oxide deficiency inhibits the reaction [Clofibrate results in increased expression of PPARA protein]
Nitric Oxide deficiency results in increased expression of PPARA mRNA; Nitric Oxide deficiency results in increased expression of PPARA protein
CTD PMID:15018640 PMID:16054168 PMID:16411023 PMID:19834340 PMID:21791144 NCBI chr15:85,734,910...85,806,851
Ensembl chr15:85,734,983...85,802,819
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma multiple interactions
increases expression
ISO
EXP
[rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide
[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide]
Nitric Oxide deficiency results in increased expression of PPARG protein
15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]; ciglitazone inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]; GW 1929 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]; PPARG protein affects the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]
CTD PMID:12847270 PMID:16527820 PMID:17063326 PMID:18041089 NCBI chr 6:115,360,879...115,490,404
Ensembl chr 6:115,360,951...115,490,399
JBrowse link
G Ppm1d protein phosphatase 1D magnesium-dependent, delta isoform increases expression ISO Nitric Oxide results in increased expression of PPM1D mRNA CTD PMID:15126337 NCBI chr11:85,311,254...85,347,071
Ensembl chr11:85,311,244...85,347,066
JBrowse link
G Ppm1g protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform decreases expression EXP Nitric Oxide deficiency results in decreased expression of PPM1G mRNA CTD PMID:15878706 NCBI chr 5:31,202,668...31,220,545
Ensembl chr 5:31,202,664...31,220,687
JBrowse link
G Ppp3ca protein phosphatase 3, catalytic subunit, alpha isoform decreases expression EXP Nitric Oxide deficiency results in decreased expression of PPP3CA mRNA CTD PMID:15878706 NCBI chr 3:136,669,714...136,937,727
Ensembl chr 3:136,670,124...136,937,727
JBrowse link
G Ppp5c protein phosphatase 5, catalytic subunit decreases expression EXP Nitric Oxide deficiency results in decreased expression of PPP5C mRNA CTD PMID:15878706 NCBI chr 7:17,004,640...17,027,914
Ensembl chr 7:17,004,640...17,027,924
JBrowse link
G Prdm2 PR domain containing 2, with ZNF domain increases expression ISO Nitric Oxide results in increased expression of PRDM2 mRNA CTD PMID:23546878 NCBI chr 4:143,107,391...143,212,769
Ensembl chr 4:143,107,391...143,212,995
JBrowse link
G Prim2 DNA primase, p58 subunit decreases expression EXP Nitric Oxide deficiency results in decreased expression of PRIM2 mRNA CTD PMID:15878706 NCBI chr 1:33,453,808...33,669,808
Ensembl chr 1:33,453,810...33,669,795
JBrowse link
G Prkaa1 protein kinase, AMP-activated, alpha 1 catalytic subunit multiple interactions ISO PRKAA1 protein affects the reaction [Fenofibrate results in increased abundance of Nitric Oxide] CTD PMID:20580385 NCBI chr15:5,143,861...5,181,899
Ensembl chr15:5,143,861...5,181,899
JBrowse link
G Prkca protein kinase C, alpha multiple interactions ISO Nitric Oxide deficiency promotes the reaction [Brimonidine Tartrate affects the localization of PRKCA protein] CTD PMID:12388232 NCBI chr11:107,933,387...108,343,888
Ensembl chr11:107,933,387...108,343,928
JBrowse link
G Prkcd protein kinase C, delta multiple interactions ISO Nitric Oxide deficiency inhibits the reaction [Brimonidine Tartrate affects the localization of PRKCD protein] CTD PMID:12388232 NCBI chr14:30,595,353...30,626,414
Ensembl chr14:30,595,354...30,626,210
JBrowse link
G Prl prolactin multiple interactions ISO 2-mercaptomethyl-3-guanidinoethylthiopropionic acid inhibits the reaction [[PRL co-treated with furylacryloylalanylarginine co-treated with Testosterone] results in increased abundance of Nitric Oxide]; [PRL co-treated with furylacryloylalanylarginine co-treated with Testosterone] results in increased abundance of Nitric Oxide; [PRL co-treated with furylacryloylalanylarginine] results in increased abundance of Nitric Oxide; [PRL results in increased expression of CPD mRNA] which results in increased chemical synthesis of Nitric Oxide CTD PMID:21688280 NCBI chr13:27,057,570...27,065,204
Ensembl chr13:27,057,570...27,065,205
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 multiple interactions ISO Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of PTGS1 mRNA] CTD PMID:21983654 NCBI chr 2:36,216,742...36,258,593
Ensembl chr 2:36,230,426...36,252,272
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
decreases expression
ISO [Ouabain results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Nitric Oxide
Nitric Oxide deficiency results in decreased expression of PTGS2 mRNA
CTD PMID:18976649 PMID:21983654 NCBI chr 1:150,100,031...150,108,234
Ensembl chr 1:150,100,031...150,108,227
JBrowse link
G Ptk2 PTK2 protein tyrosine kinase 2 decreases expression EXP Nitric Oxide deficiency results in decreased expression of PTK2 mRNA CTD PMID:15878706 NCBI chr15:73,205,102...73,423,820
Ensembl chr15:73,205,102...73,423,280
JBrowse link
G Pttg1 pituitary tumor-transforming gene 1 increases expression EXP Nitric Oxide deficiency results in increased expression of PTTG1 mRNA CTD PMID:15878706 NCBI chr11:43,420,244...43,427,463
Ensembl chr11:43,420,250...43,426,251
JBrowse link
G Raf1 v-raf-leukemia viral oncogene 1 multiple interactions ISO [Lipopolysaccharides results in increased activity of RAF1 protein] which results in decreased secretion of Nitric Oxide CTD PMID:19039081 NCBI chr 6:115,618,569...115,676,635
Ensembl chr 6:115,618,067...115,676,635
JBrowse link
G Ramp1 receptor (calcitonin) activity modifying protein 1 increases expression ISO Nitric Oxide deficiency results in increased expression of RAMP1 mRNA; Nitric Oxide deficiency results in increased expression of RAMP1 protein CTD PMID:16326922 NCBI chr 1:91,179,822...91,225,196
Ensembl chr 1:91,179,822...91,225,196
JBrowse link
G Ramp2 receptor (calcitonin) activity modifying protein 2 multiple interactions
increases expression
ISO Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP2 protein]; Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP2 protein]
Nitric Oxide deficiency results in increased expression of RAMP2 mRNA; Nitric Oxide deficiency results in increased expression of RAMP2 protein
CTD PMID:16326922 NCBI chr11:101,246,334...101,248,250
Ensembl chr11:101,246,028...101,259,546
JBrowse link
G Ramp3 receptor (calcitonin) activity modifying protein 3 multiple interactions
increases expression
ISO Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP3 protein]; Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP3 protein]
Nitric Oxide deficiency results in increased expression of RAMP3 mRNA; Nitric Oxide deficiency results in increased expression of RAMP3 protein
CTD PMID:16326922 NCBI chr11:6,658,506...6,677,478
Ensembl chr11:6,658,521...6,677,475
JBrowse link
G Rap1a RAS-related protein 1a multiple interactions ISO Nitric Oxide promotes the reaction [ITGB2 protein results in increased activity of RAP1A protein] CTD PMID:16963453 NCBI chr 3:105,727,260...105,801,394
Ensembl chr 3:105,727,267...105,801,336
JBrowse link
G Rap2a RAS related protein 2a multiple interactions ISO Nitric Oxide promotes the reaction [ITGB2 protein results in increased activity of RAP2A protein] CTD PMID:16963453 NCBI chr14:120,478,461...120,507,194
Ensembl chr14:120,478,444...120,507,194
JBrowse link
G Rasd1 RAS, dexamethasone-induced 1 multiple interactions ISO Nitric Oxide promotes the reaction [[RASD1 protein binds to ACBD3 protein binds to SLC11A2 protein] which results in increased uptake of Iron] CTD PMID:16908409 NCBI chr11:59,963,181...59,964,944
Ensembl chr11:59,963,181...59,964,944
JBrowse link
G Rbbp6 retinoblastoma binding protein 6, ubiquitin ligase decreases expression EXP Nitric Oxide deficiency results in decreased expression of RBBP6 mRNA CTD PMID:15878706 NCBI chr 7:122,969,637...123,002,572
Ensembl chr 7:122,965,686...123,002,557
JBrowse link
G Rcn1 reticulocalbin 1 multiple interactions ISO [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which affects the expression of RCN1 protein CTD PMID:19320461 NCBI chr 2:105,385,948...105,399,319
Ensembl chr 2:105,386,291...105,399,319
JBrowse link
G Rdx radixin increases phosphorylation ISO Nitric Oxide deficiency results in increased phosphorylation of RDX protein CTD PMID:14732730 NCBI chr 9:52,047,150...52,088,738
Ensembl chr 9:52,047,173...52,100,463
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) affects localization ISO Nitric Oxide deficiency affects the localization of RELA protein CTD PMID:19631198 NCBI chr19:5,637,442...5,648,134
Ensembl chr19:5,637,483...5,648,130
JBrowse link
G Ren1 renin 1 structural multiple interactions
increases expression
ISO [Nitric Oxide deficiency co-treated with Sodium Chloride, Dietary] results in increased expression of REN protein; Nebivolol inhibits the reaction [Nitric Oxide deficiency results in increased expression of REN protein] CTD PMID:7541960 PMID:10679504 PMID:12806161 PMID:15123544 NCBI chr 1:133,350,674...133,360,320
Ensembl chr 1:133,350,510...133,360,325
JBrowse link
G Retn resistin multiple interactions
increases expression
EXP
ISO
[[TNF protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] which results in decreased expression of RETN mRNA
Nitric Oxide deficiency results in increased expression of RETN mRNA
CTD PMID:17063326 PMID:18369347 NCBI chr 8:3,655,770...3,659,818
Ensembl chr 8:3,655,770...3,660,110
JBrowse link
G Rhoa ras homolog family member A multiple interactions ISO Nitric Oxide deficiency affects the localization of and results in increased activity of RHOA protein CTD PMID:14732730 NCBI chr 9:108,306,160...108,337,943
Ensembl chr 9:108,306,129...108,337,934
JBrowse link
G Rpl10a ribosomal protein L10A increases expression EXP Nitric Oxide deficiency results in increased expression of RPL10A mRNA CTD PMID:15878706 NCBI chr17:28,328,471...28,331,033
Ensembl chr17:28,328,471...28,331,033
JBrowse link
G Rpl12 ribosomal protein L12 increases expression EXP Nitric Oxide deficiency results in increased expression of RPL12 mRNA CTD PMID:15878706 NCBI chr 2:32,961,712...32,964,045
Ensembl chr 2:32,961,559...32,965,345
JBrowse link
G Rpl3 ribosomal protein L3 decreases expression EXP Nitric Oxide deficiency results in decreased expression of RPL3 mRNA CTD PMID:15878706 NCBI chr15:80,077,781...80,083,406
Ensembl chr15:80,077,791...80,091,868
JBrowse link
G Rpl8 ribosomal protein L8 increases expression EXP Nitric Oxide deficiency results in increased expression of RPL8 mRNA CTD PMID:15878706 NCBI chr15:76,904,071...76,906,318
Ensembl chr15:76,904,078...76,906,314
JBrowse link
G Rplp0 ribosomal protein, large, P0 increases expression EXP Nitric Oxide deficiency results in increased expression of RPLP0 mRNA CTD PMID:15878706 NCBI chr 5:115,559,467...115,563,729
Ensembl chr 5:115,559,467...115,563,727
JBrowse link
G Rplp1 ribosomal protein, large, P1 increases expression EXP Nitric Oxide deficiency results in increased expression of RPLP1 mRNA CTD PMID:15878706 NCBI chr 9:61,913,283...61,914,510
Ensembl chr 9:61,913,284...61,914,542
JBrowse link
G Rps12 ribosomal protein S12 increases expression EXP Nitric Oxide deficiency results in increased expression of RPS12 mRNA CTD PMID:15878706 NCBI chr10:23,785,183...23,787,383
Ensembl chr10:23,785,183...23,787,275
JBrowse link
G Rps14 ribosomal protein S14 increases expression EXP Nitric Oxide deficiency results in increased expression of RPS14 mRNA CTD PMID:15878706 NCBI chr18:60,774,596...60,778,546
Ensembl chr18:60,747,098...60,778,546
JBrowse link
G Rps15 ribosomal protein S15 increases expression EXP Nitric Oxide deficiency results in increased expression of RPS15 mRNA CTD PMID:15878706 NCBI chr10:80,292,431...80,294,114
Ensembl chr10:80,292,453...80,294,114
JBrowse link
G Rps20 ribosomal protein S20 increases expression EXP Nitric Oxide deficiency results in increased expression of RPS20 mRNA CTD PMID:15878706 NCBI chr 4:3,831,584...3,835,655
Ensembl chr 4:3,831,334...3,835,665
JBrowse link
G Rps26 ribosomal protein S26 increases expression EXP Nitric Oxide deficiency results in increased expression of RPS26 mRNA CTD PMID:15878706 NCBI chr10:128,624,529...128,626,506
Ensembl chr10:128,624,534...128,626,747
JBrowse link
G Rps6 ribosomal protein S6 increases expression EXP Nitric Oxide deficiency results in increased expression of RPS6 mRNA CTD PMID:15878706 NCBI chr 4:86,854,099...86,857,367
Ensembl chr 4:86,854,660...86,857,412
JBrowse link
G Rps6kb1 ribosomal protein S6 kinase, polypeptide 1 multiple interactions ISO [resveratrol results in decreased activity of RPS6KB1 protein] which results in increased abundance of Nitric Oxide; [Sirolimus results in decreased activity of RPS6KB1 protein] which results in increased abundance of Nitric Oxide CTD PMID:21544240 NCBI chr11:86,498,869...86,544,885
Ensembl chr11:86,498,871...86,544,805
JBrowse link
G Rps7 ribosomal protein S7 increases expression EXP Nitric Oxide deficiency results in increased expression of RPS7 mRNA CTD PMID:15878706 NCBI chr12:28,630,847...28,635,953
Ensembl chr12:28,630,854...28,635,953
JBrowse link
G Rps8 ribosomal protein S8 increases expression EXP Nitric Oxide deficiency results in increased expression of RPS8 mRNA CTD PMID:15878706 NCBI chr 4:117,153,836...117,156,132
Ensembl chr 4:117,153,827...117,156,243
JBrowse link
G S100b S100 protein, beta polypeptide, neural multiple interactions
increases secretion
EXP
ISO
[S100B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; PARP1 gene mutant form inhibits the reaction [S100B protein results in increased secretion of Nitric Oxide] CTD PMID:16376947 PMID:27444121 NCBI chr10:76,253,836...76,261,319
Ensembl chr10:76,253,853...76,261,159
JBrowse link
G Sap30bp SAP30 binding protein decreases expression EXP Nitric Oxide deficiency results in decreased expression of SAP30BP mRNA CTD PMID:15878706 NCBI chr11:115,933,578...115,965,534
Ensembl chr11:115,933,282...115,966,725
JBrowse link
G Scgb1a1 secretoglobin, family 1A, member 1 (uteroglobin) decreases expression ISO Nitric Oxide results in decreased expression of SCGB1A1 protein CTD PMID:15764486 NCBI chr19:9,083,642...9,087,956
Ensembl chr19:9,083,636...9,087,958
JBrowse link
G Sdc2 syndecan 2 increases expression EXP Nitric Oxide deficiency results in increased expression of SDC2 mRNA CTD PMID:15878706 NCBI chr15:32,920,723...33,034,721
Ensembl chr15:32,920,723...33,034,935
JBrowse link
G Sele selectin, endothelial cell multiple interactions ISO Nitric Oxide deficiency inhibits the reaction [nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased expression of SELE protein]] CTD PMID:14762100 NCBI chr 1:164,039,614...164,058,487
Ensembl chr 1:164,048,234...164,057,677
JBrowse link
G Setdb2 SET domain, bifurcated 2 increases expression ISO Nitric Oxide results in increased expression of SETDB2 mRNA CTD PMID:23546878 NCBI chr14:59,402,009...59,440,880
Ensembl chr14:59,402,009...59,440,884
JBrowse link
G Sftpa1 surfactant associated protein A1 multiple interactions
decreases expression
ISO bosentan inhibits the reaction [Nitric Oxide results in decreased expression of SFTPA1 mRNA]; PD 156707 inhibits the reaction [Nitric Oxide results in decreased expression of SFTPA1 mRNA] CTD PMID:15640287 NCBI chr14:41,131,788...41,136,373
Ensembl chr14:41,131,782...41,136,452
JBrowse link
G Sftpb surfactant associated protein B multiple interactions
decreases expression
ISO bosentan inhibits the reaction [Nitric Oxide results in decreased expression of SFTPB mRNA]; PD 156707 inhibits the reaction [Nitric Oxide results in decreased expression of SFTPB mRNA] CTD PMID:15640287 NCBI chr 6:72,304,610...72,314,373
Ensembl chr 6:72,304,610...72,314,371
JBrowse link
G Sftpc surfactant associated protein C multiple interactions
decreases expression
ISO bosentan inhibits the reaction [Nitric Oxide results in decreased expression of SFTPC mRNA]; PD 156707 inhibits the reaction [Nitric Oxide results in decreased expression of SFTPC mRNA] CTD PMID:15640287 NCBI chr14:70,520,941...70,524,081
Ensembl chr14:70,520,949...70,524,081
JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO SIRT1 protein affects the reaction [INS protein results in increased secretion of Nitric Oxide]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]] CTD PMID:20960276 NCBI chr10:63,319,005...63,339,035
Ensembl chr10:63,319,005...63,381,704
JBrowse link
G Slc11a2 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 multiple interactions
affects expression
ISO
EXP
Nitric Oxide promotes the reaction [[RASD1 protein binds to ACBD3 protein binds to SLC11A2 protein] which results in increased uptake of Iron]
Nitric Oxide affects the expression of SLC11A2 protein alternative form
CTD PMID:16232120 PMID:16908409 NCBI chr15:100,387,898...100,424,209
Ensembl chr15:100,387,898...100,425,072
JBrowse link
G Slc40a1 solute carrier family 40 (iron-regulated transporter), member 1 decreases expression ISO Nitric Oxide deficiency results in decreased expression of SLC40A1 protein CTD PMID:24184442 NCBI chr 1:45,908,070...45,926,532
Ensembl chr 1:45,908,068...45,926,523
JBrowse link
G Slc4a2 solute carrier family 4 (anion exchanger), member 2 multiple interactions ISO Nitric Oxide inhibits the reaction [SLC4A2 protein promotes the reaction [Cyclic AMP results in increased transport of Bicarbonates]] CTD PMID:12612912 NCBI chr 5:24,423,761...24,440,947
Ensembl chr 5:24,423,837...24,440,950
JBrowse link
G Slc5a2 solute carrier family 5 (sodium/glucose cotransporter), member 2 decreases activity ISO Nitric Oxide deficiency results in decreased activity of SLC5A2 protein CTD PMID:17940347 NCBI chr 7:128,265,683...128,272,430
Ensembl chr 7:128,265,657...128,272,430
JBrowse link
G Slc7a7 solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 decreases abundance ISO SLC7A7 protein results in decreased abundance of Nitric Oxide CTD PMID:11544277 NCBI chr14:54,369,442...54,420,068
Ensembl chr14:54,369,442...54,417,780
JBrowse link
G Smad3 SMAD family member 3 multiple interactions ISO [SMAD4 protein co-treated with SMAD3 protein] affects the susceptibility to Nitric Oxide; Nitric Oxide results in increased activity of [SMAD4 protein binds to SMAD3 protein] CTD PMID:15949472 NCBI chr 9:63,646,766...63,757,994
Ensembl chr 9:63,646,767...63,757,994
JBrowse link
G Smad4 SMAD family member 4 multiple interactions ISO [SMAD4 protein co-treated with SMAD3 protein] affects the susceptibility to Nitric Oxide; Nitric Oxide results in increased activity of [SMAD4 protein binds to SMAD3 protein] CTD PMID:15949472 NCBI chr18:73,634,790...73,703,791
Ensembl chr18:73,639,009...73,703,780
JBrowse link
G Snca synuclein, alpha multiple interactions ISO [Maneb promotes the reaction [SNCA gene mutant form results in increased susceptibility to Paraquat]] which results in increased abundance of Nitric Oxide; [Paraquat promotes the reaction [SNCA gene mutant form results in increased susceptibility to Maneb]] which results in increased abundance of Nitric Oxide CTD PMID:24290359 NCBI chr 6:60,731,573...60,829,855
Ensembl chr 6:60,731,575...60,829,855
JBrowse link
G Snta1 syntrophin, acidic 1 decreases expression EXP Nitric Oxide deficiency results in decreased expression of SNTA1 mRNA CTD PMID:15878706 NCBI chr 2:154,376,313...154,408,107
Ensembl chr 2:154,376,313...154,408,099
JBrowse link
G Sod1 superoxide dismutase 1, soluble increases abundance
multiple interactions
decreases response to substance
EXP
ISO
SOD1 protein results in increased abundance of Nitric Oxide
Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of SOD1 mRNA]
SOD1 protein inhibits the reaction [[spermine nitric oxide complex results in increased abundance of Nitric Oxide] which results in increased abundance of Superoxides]; SOD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein]; SOD1 protein inhibits the reaction [Nitric Oxide results in increased abundance of Peroxynitrous Acid]
Nitric Oxide deficiency results in decreased susceptibility to SOD1 protein mutant form
CTD PMID:12489993 PMID:19845829 PMID:21443684 PMID:21983654 NCBI chr16:90,220,762...90,226,333
Ensembl chr16:90,220,754...90,226,329
JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial increases expression
decreases abundance
affects abundance
multiple interactions
ISO Nitric Oxide deficiency results in increased expression of SOD2 protein
SOD2 protein results in decreased abundance of Nitric Oxide
SOD2 protein affects the abundance of Nitric Oxide
[NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in increased expression of SOD2 mRNA; [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in increased expression of SOD2 protein
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of and results in increased activity of SOD2 protein]; 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA]; [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of and results in increased activity of SOD2 protein; [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of and results in increased activity of SOD2 protein; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA; Dactinomycin inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA]; Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of SOD2 mRNA]; SOD2 protein inhibits the reaction [IL1B protein results in increased chemical synthesis of Nitric Oxide]; tempol inhibits the reaction [Nitric Oxide deficiency results in increased expression of SOD2 protein]
CTD PMID:9576743 PMID:14996425 PMID:15925750 PMID:19320461 PMID:20110409 PMID:21983654 PMID:23964924 NCBI chr17:13,007,839...13,018,119
Ensembl chr17:13,006,846...13,040,063
JBrowse link
G Spp1 secreted phosphoprotein 1 decreases expression EXP Nitric Oxide deficiency results in decreased expression of SPP1 mRNA CTD PMID:15878706 NCBI chr 5:104,435,111...104,441,053
Ensembl chr 5:104,435,118...104,441,050
JBrowse link
G Src Rous sarcoma oncogene multiple interactions ISO [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide CTD PMID:18296501 NCBI chr 2:157,423,906...157,471,838
Ensembl chr 2:157,418,444...157,471,862
JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions EXP STAT1 protein promotes the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] CTD PMID:23106696 NCBI chr 1:52,119,438...52,161,865
Ensembl chr 1:52,119,440...52,161,865
JBrowse link
G Stat5a signal transducer and activator of transcription 5A decreases expression
multiple interactions
EXP Nitric Oxide results in decreased expression of STAT5A protein
STAT5A protein affects the reaction [Nitric Oxide results in decreased expression of ACO1 mRNA]
CTD PMID:16886906 NCBI chr11:100,859,351...100,885,169
Ensembl chr11:100,859,351...100,885,169
JBrowse link
G Stat5b signal transducer and activator of transcription 5B multiple interactions
decreases expression
EXP STAT5B protein affects the reaction [Nitric Oxide results in decreased expression of ACO1 mRNA]
Nitric Oxide results in decreased expression of STAT5B protein
CTD PMID:16886906 NCBI chr11:100,780,731...100,859,004
Ensembl chr11:100,780,731...100,850,724
JBrowse link
G Suv39h2 suppressor of variegation 3-9 2 increases expression ISO Nitric Oxide results in increased expression of SUV39H2 mRNA CTD PMID:23546878 NCBI chr 2:3,455,815...3,474,986
Ensembl chr 2:3,455,815...3,475,031
JBrowse link
G Syn1 synapsin I increases expression EXP Nitric Oxide deficiency results in increased expression of SYN1 mRNA CTD PMID:15878706 NCBI chr  X:20,860,511...20,920,918
Ensembl chr  X:20,860,511...20,921,004
JBrowse link
G Taldo1 transaldolase 1 multiple interactions
decreases abundance
EXP Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased abundance of Nitric Oxide] CTD PMID:19436114 NCBI chr 7:141,392,160...141,402,976
Ensembl chr 7:141,392,199...141,402,968
JBrowse link
G Tbca tubulin cofactor A increases expression EXP Nitric Oxide deficiency results in increased expression of TBCA mRNA CTD PMID:15878706 NCBI chr13:94,788,920...94,842,923
Ensembl chr13:94,788,910...94,842,922
JBrowse link
G Tfrc transferrin receptor multiple interactions
decreases expression
ISO [[fluvastatin results in increased expression of NOS2] which results in increased abundance of Nitric Oxide] which results in decreased expression of TFRC
Nitric Oxide deficiency results in decreased expression of TFRC protein
CTD PMID:24184442 PMID:24964743 NCBI chr16:32,608,896...32,632,794
Ensembl chr16:32,608,920...32,632,794
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
increases expression
ISO candesartan inhibits the reaction [Nitric Oxide deficiency results in increased expression of TGFB1 mRNA]; Nitric Oxide inhibits the reaction [Paraquat results in increased expression of TGFB1 protein] CTD PMID:15820443 PMID:16778335 NCBI chr 7:25,687,002...25,705,077
Ensembl chr 7:25,687,002...25,705,077
JBrowse link
G Thbd thrombomodulin multiple interactions
decreases expression
ISO candesartan inhibits the reaction [Nitric Oxide deficiency results in decreased expression of THBD protein]; Hydralazine inhibits the reaction [Nitric Oxide deficiency results in decreased expression of THBD protein] CTD PMID:16778335 NCBI chr 2:148,404,471...148,408,188
Ensembl chr 2:148,404,466...148,408,188
JBrowse link
G Timp2 tissue inhibitor of metalloproteinase 2 decreases expression ISO Nitric Oxide results in decreased expression of TIMP2 mRNA; Nitric Oxide results in decreased expression of TIMP2 protein CTD PMID:18796497 NCBI chr11:118,301,061...118,355,411
Ensembl chr11:118,301,069...118,355,740
JBrowse link
G Tinf2 Terf1 (TRF1)-interacting nuclear factor 2 increases expression EXP Nitric Oxide deficiency results in increased expression of TINF2 mRNA CTD PMID:15878706 NCBI chr14:55,676,208...55,682,159
Ensembl chr14:55,674,689...55,681,820
JBrowse link
G Tjp1 tight junction protein 1 decreases expression
multiple interactions
ISO
EXP
Nitric Oxide deficiency results in decreased expression of TJP1 protein
[NOS2 protein results in increased chemical synthesis of Nitric Oxide] which results in decreased expression of TJP1 mRNA
CTD PMID:15763998 PMID:25870319 NCBI chr 7:65,296,165...65,527,850
Ensembl chr 7:65,296,165...65,527,781
JBrowse link
G Tk1 thymidine kinase 1 increases mutagenesis ISO Nitric Oxide results in increased mutagenesis of TK1 gene CTD PMID:22303861 PMID:28454271 NCBI chr11:117,815,519...117,826,087
Ensembl chr11:117,815,526...117,826,092
JBrowse link
G Tle5 TLE family member 5, transcriptional modulator increases expression EXP Nitric Oxide deficiency results in increased expression of TLE5 mRNA CTD PMID:15878706 NCBI chr10:81,559,444...81,566,371
Ensembl chr10:81,559,488...81,566,362
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP TLR4 gene mutant form inhibits the reaction [Fungal Polysaccharides results in increased abundance of Nitric Oxide]; TLR4 protein affects the reaction [Plant Extracts results in increased chemical synthesis of Nitric Oxide]; TLR4 protein affects the reaction [Polysaccharides results in increased chemical synthesis of Nitric Oxide] CTD PMID:22687552 PMID:23246459 NCBI chr 4:66,827,551...66,846,581
Ensembl chr 4:66,827,584...66,930,284
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases abundance
increases expression
increases metabolic processing
decreases abundance
increases secretion
ISO
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [rhodojaponin II inhibits the reaction [TNF protein results in increased secretion of Nitric Oxide]]; [IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide; [IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [IL5 protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [NOS2 protein results in increased abundance of Nitric Oxide] affects the susceptibility to [IL1B protein co-treated with TNF protein co-treated with IFNG protein]; Acetylcysteine inhibits the reaction [TNF results in increased abundance of Nitric Oxide]; Alginic Acid inhibits the reaction [TNF protein results in increased abundance of Nitric Oxide]; allicin inhibits the reaction [TNF protein results in increased abundance of Nitric Oxide]; Ascorbic Acid inhibits the reaction [TNF protein results in increased abundance of Nitric Oxide]; Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Dactinomycin inhibits the reaction [TNF results in increased abundance of Nitric Oxide]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate promotes the reaction [rhodojaponin II inhibits the reaction [TNF protein results in increased secretion of Nitric Oxide]]; martentoxin, Buthus martensi inhibits the reaction [TNF protein results in increased abundance of Nitric Oxide]; N,N-diacetylcystine inhibits the reaction [TNF protein results in decreased abundance of Nitric Oxide]; pyrrolidine dithiocarbamic acid promotes the reaction [rhodojaponin II inhibits the reaction [TNF protein results in increased secretion of Nitric Oxide]]; rhodojaponin II inhibits the reaction [TNF protein results in increased secretion of Nitric Oxide]; Wortmannin inhibits the reaction [Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]]
[[TNF protein co-treated with IFNG protein] affects the expression of NOS2 mRNA] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [[TNF protein co-treated with IFNG protein] affects the expression of NOS2 protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; [[TNF protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] which results in decreased expression of RETN mRNA; [IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide; [Lipopolysaccharides co-treated with TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide; [Nitric Oxide Donors results in increased abundance of Nitric Oxide] inhibits the reaction [[TNF protein co-treated with Galactosamine] results in increased activity of CASP3 protein]; [TNF co-treated with IL1B co-treated with IFNG] results in increased abundance of Nitric Oxide; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide; [TNF protein co-treated with IFNG protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; [TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide; [TNF protein co-treated with IFNG protein] results in increased secretion of Nitric Oxide; [TNF protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; [TNF protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; Bee Venoms inhibits the reaction [[TNF protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; cobaltous chloride promotes the reaction [[[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Dexamethasone inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; Estriol inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide]]; Guanidines analog inhibits the reaction [[Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide]; Guanidines inhibits the reaction [Simvastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide]]; IL4 protein inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; lead chloride inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; manganese chloride promotes the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; manganese chloride promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]; Manganese promotes the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; Manganese promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]; Melitten inhibits the reaction [[TNF protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide]]; NFKBIA protein affects the reaction [manganese chloride promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]]; NFKBIA protein affects the reaction [Manganese promotes the reaction [TNF protein co-treated with and results in increased chemical synthesis of IFNG protein co-treated with and results in increased chemical synthesis of Nitric Oxide]]; nickel chloride promotes the reaction [[[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] affects the localization of Zinc]; Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT1 mRNA]; Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT2 mRNA]; NOS2 protein promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; NOS2 protein promotes the reaction [cobaltous chloride promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]]; NOS2 protein promotes the reaction [nickel chloride promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]]; pimagedine inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]; Plant Extracts inhibits the reaction [[Lipopolysaccharides results in increased expression of TNF protein] which results in increased chemical synthesis of Nitric Oxide]; Pravastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide]; Progesterone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; Quercetin inhibits the reaction [TNF protein results in increased abundance of Nitric Oxide]; Simvastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide]; sodium arsenite inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Y 27632 promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased abundance of Nitric Oxide]
Nitric Oxide deficiency results in increased expression of TNF protein; Nitric Oxide results in increased expression of TNF protein
TNF protein results in increased metabolism of Nitric Oxide
7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine inhibits the reaction [TNF protein results in increased abundance of Nitric Oxide]; [IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide; [IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; [IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide; [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide; [TNF co-treated with IL1B co-treated with IFNG] results in increased abundance of Nitric Oxide; [TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide; Acetylcysteine inhibits the reaction [Nitric Oxide deficiency results in increased expression of TNF protein]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; KMUP 1 inhibits the reaction [TNF protein results in increased abundance of Nitric Oxide]; Polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; S-methylisothiopseudouronium inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; TNF protein affects the reaction [Lipopolysaccharides results in increased secretion of Nitric Oxide]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]; zaprinast inhibits the reaction [TNF protein results in increased abundance of Nitric Oxide]
TNF protein results in increased abundance of Nitric Oxide; TNF results in increased abundance of Nitric Oxide
Nitric Oxide results in increased secretion of TNF protein; TNF protein results in increased secretion of Nitric Oxide
CTD PMID:7519435 PMID:8341679 PMID:8903404 PMID:8975779 PMID:9388267 PMID:10706834 PMID:10909967 PMID:11063824 PMID:11282106 PMID:12612912 PMID:12723939 PMID:13678430 PMID:14617770 PMID:14623498 PMID:15223066 PMID:15451797 PMID:15485488 PMID:16168523 PMID:16366677 PMID:16492401 PMID:16754782 PMID:16968468 PMID:17026986 PMID:17067557 PMID:17157857 PMID:17729120 PMID:18206661 PMID:18207479 PMID:18369347 PMID:19393675 PMID:20626112 PMID:20708382 PMID:21943492 PMID:23439570 PMID:24086172 PMID:25766886 PMID:32613688 NCBI chr17:35,199,367...35,202,007
Ensembl chr17:35,199,381...35,202,007
JBrowse link
G Trp53 transformation related protein 53 multiple interactions
increases phosphorylation
decreases expression
affects response to substance
increases glutathionylation
increases expression
ISO
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Nitric Oxide results in increased phosphorylation of TP53 protein]; [Nitric Oxide Donors results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein; Caffeine inhibits the reaction [Nitric Oxide results in increased phosphorylation of TP53 protein]; wortmannin inhibits the reaction [Nitric Oxide results in increased phosphorylation of TP53 protein]
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of TRP53 mRNA
Nitric Oxide results in decreased expression of TRP53 protein
[7-nitroindazole results in decreased chemical synthesis of Nitric Oxide] inhibits the reaction [Paraquat results in increased phosphorylation of TP53 protein]; [NOS2 protein results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein; [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein
TP53 protein affects the susceptibility to Nitric Oxide
Nitric Oxide results in increased glutathionylation of TP53 protein
Nitric Oxide results in increased expression of TP53 protein
CTD PMID:7673702 PMID:8982730 PMID:9743513 PMID:10608825 PMID:14634119 PMID:15177039 PMID:15979383 PMID:16024610 PMID:17555331 PMID:20478973 NCBI chr11:69,580,348...69,591,873
Ensembl chr11:69,580,359...69,591,873
JBrowse link
G Trp53bp1 transformation related protein 53 binding protein 1 decreases expression EXP Nitric Oxide deficiency results in decreased expression of TRP53BP1 mRNA CTD PMID:15878706 NCBI chr 2:121,194,835...121,296,354
Ensembl chr 2:121,193,281...121,271,407
JBrowse link
G Txndc5 thioredoxin domain containing 5 multiple interactions ISO [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which affects the expression of TXNDC5 protein CTD PMID:19320461 NCBI chr13:38,500,266...38,528,824
Ensembl chr13:38,500,079...38,528,824
JBrowse link
G Ubc ubiquitin C increases expression EXP Nitric Oxide deficiency results in increased expression of UBC mRNA CTD PMID:15878706 NCBI chr 5:125,385,965...125,390,017
Ensembl chr 5:125,385,965...125,390,202
JBrowse link
G Ube2l3 ubiquitin-conjugating enzyme E2L 3 decreases expression EXP Nitric Oxide deficiency results in decreased expression of UBE2L3 mRNA CTD PMID:15878706 NCBI chr16:17,152,015...17,201,512
Ensembl chr16:17,152,013...17,202,649
JBrowse link
G Ucn urocortin increases abundance ISO UCN protein results in increased abundance of Nitric Oxide CTD PMID:20237592 NCBI chr 5:31,137,989...31,138,895
Ensembl chr 5:31,138,063...31,138,829
JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression
increases secretion
ISO Nitric Oxide deficiency results in decreased expression of VEGFA mRNA
VEGFA protein results in increased secretion of Nitric Oxide
CTD PMID:15249212 PMID:16733097 NCBI chr17:46,016,993...46,032,377
Ensembl chr17:46,016,993...46,032,369
JBrowse link
G Wt1 Wilms tumor 1 homolog increases expression ISO Nitric Oxide results in increased expression of WT1 mRNA CTD PMID:21443142 NCBI chr 2:105,126,529...105,173,614
Ensembl chr 2:105,126,529...105,173,616
JBrowse link
G Xdh xanthine dehydrogenase multiple interactions ISO XDH protein promotes the reaction [[Raloxifene Hydrochloride results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide] CTD PMID:20888885 NCBI chr17:73,883,895...73,950,397
Ensembl chr17:73,883,895...73,950,196
JBrowse link
G Xiap X-linked inhibitor of apoptosis decreases expression
increases expression
ISO
EXP
Nitric Oxide results in decreased expression of XIAP mRNA
Nitric Oxide results in increased expression of XIAP protein
CTD PMID:14634119 PMID:15126337 NCBI chr  X:42,059,613...42,109,664
Ensembl chr  X:42,059,679...42,109,656
JBrowse link
G Zfp422 zinc finger protein 422 decreases expression EXP Nitric Oxide deficiency results in decreased expression of ZFP422 mRNA CTD PMID:15878706 NCBI chr 6:116,624,016...116,628,999
Ensembl chr 6:116,624,016...116,628,999
JBrowse link
nitrogen dioxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aamdc adipogenesis associated Mth938 domain containing multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of AAMDC 5' UTR CTD PMID:28843141 NCBI chr 7:97,550,329...97,579,557
Ensembl chr 7:97,550,331...97,579,497
JBrowse link
G Abcc2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 multiple interactions ISO ABCC2 gene SNP affects the susceptibility to [Air Pollutants results in increased abundance of Nitrogen Dioxide] CTD PMID:29681089 NCBI chr19:43,782,308...43,838,332
Ensembl chr19:43,782,192...43,840,740
JBrowse link
G Adora2b adenosine A2b receptor multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of ADORA2B gene CTD PMID:29935799 NCBI chr11:62,248,984...62,266,452
Ensembl chr11:62,248,984...62,266,453
JBrowse link
G Alb albumin increases expression ISO Nitrogen Dioxide results in increased expression of ALB mRNA CTD PMID:27206323 NCBI chr 5:90,460,870...90,476,602
Ensembl chr 5:90,460,897...90,476,602
JBrowse link
G Ankrd45 ankyrin repeat domain 45 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of ANKRD45 gene CTD PMID:29935799 NCBI chr 1:161,142,447...161,170,510
Ensembl chr 1:161,142,691...161,170,498
JBrowse link
G Aox1 aldehyde oxidase 1 increases expression ISO Nitrogen Dioxide results in increased expression of AOX1 mRNA CTD PMID:27206323 NCBI chr 1:58,029,809...58,106,410
Ensembl chr 1:58,029,931...58,106,413
JBrowse link
G Aqp1 aquaporin 1 decreases expression ISO Nitrogen Dioxide results in decreased expression of AQP1 mRNA CTD PMID:27206323 NCBI chr 6:55,336,299...55,348,555
Ensembl chr 6:55,336,432...55,348,555
JBrowse link
G B3galt4 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of B3GALT4 gene CTD PMID:29935799 NCBI chr17:33,949,912...33,951,488
Ensembl chr17:33,949,909...33,951,488
JBrowse link
G Bax BCL2-associated X protein increases expression
multiple interactions
ISO
EXP
Nitrogen Dioxide results in increased expression of BAX mRNA; Nitrogen Dioxide results in increased expression of BAX protein
[Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of BAX protein
CTD PMID:22621880 PMID:27521637 NCBI chr 7:45,461,695...45,466,903
Ensembl chr 7:45,461,697...45,466,898
JBrowse link
G Bbc3 BCL2 binding component 3 increases expression ISO Nitrogen Dioxide results in increased expression of BBC3 mRNA CTD PMID:27206323 NCBI chr 7:16,308,398...16,318,334
Ensembl chr 7:16,308,393...16,318,205
JBrowse link
G Bnip3 BCL2/adenovirus E1B interacting protein 3 increases expression ISO Nitrogen Dioxide results in increased expression of BNIP3 mRNA CTD PMID:27206323 NCBI chr 7:138,890,836...138,909,506
Ensembl chr 7:138,890,836...138,909,519
JBrowse link
G Cacna2d1 calcium channel, voltage-dependent, alpha2/delta subunit 1 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of CACNA2D1 gene CTD PMID:28843141 NCBI chr 5:15,934,264...16,374,511
Ensembl chr 5:15,934,691...16,374,511
JBrowse link
G Cat catalase increases expression
multiple interactions
ISO
EXP
Nitrogen Dioxide results in increased expression of CAT mRNA
[Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased expression of CAT mRNA; [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in increased methylation of CAT gene; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in decreased expression of CAT mRNA; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in increased methylation of CAT gene
CAT protein inhibits the reaction [Nitrogen Dioxide results in decreased expression of CCND1 mRNA]
CTD PMID:12600834 PMID:15336314 PMID:27448387 NCBI chr 2:103,453,904...103,485,153
Ensembl chr 2:103,453,849...103,485,160
JBrowse link
G Cbs cystathionine beta-synthase decreases activity ISO Nitrogen Dioxide results in decreased activity of CBS protein CTD PMID:19733148 NCBI chr17:31,612,623...31,637,233
Ensembl chr17:31,608,894...31,637,238
JBrowse link
G Ccl11 chemokine (C-C motif) ligand 11 increases expression EXP Nitrogen Dioxide results in increased expression of CCL11 mRNA CTD PMID:10715624 NCBI chr11:82,057,832...82,062,955
Ensembl chr11:82,057,823...82,062,955
JBrowse link
G Ccl2 chemokine (C-C motif) ligand 2 increases expression
decreases expression
EXP
ISO
Nitrogen Dioxide results in increased expression of CCL2 mRNA; Nitrogen Dioxide results in increased expression of CCL2 protein
Nitrogen Dioxide results in decreased expression of CCL2 mRNA
CTD PMID:10715624 PMID:11498801 PMID:27206323 NCBI chr11:82,035,577...82,037,452
Ensembl chr11:82,035,571...82,037,453
JBrowse link
G Ccl3 chemokine (C-C motif) ligand 3 increases expression EXP Nitrogen Dioxide results in increased expression of CCL3 mRNA CTD PMID:10715624 NCBI chr11:83,647,843...83,649,378
Ensembl chr11:83,647,844...83,649,355
JBrowse link
G Ccl5 chemokine (C-C motif) ligand 5 increases expression ISO Nitrogen Dioxide results in increased expression of CCL5 mRNA CTD PMID:27206323 NCBI chr11:83,525,778...83,530,518
Ensembl chr11:83,525,778...83,530,518
JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression
EXP CAT protein inhibits the reaction [Nitrogen Dioxide results in decreased expression of CCND1 mRNA]
Nitrogen Dioxide results in decreased expression of CCND1 mRNA; Nitrogen Dioxide results in decreased expression of CCND1 protein
CTD PMID:12600834 NCBI chr 7:144,929,931...144,939,831
Ensembl chr 7:144,929,931...144,939,925
JBrowse link
G Cd72 CD72 antigen multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of CD72 3' UTR CTD PMID:28843141 NCBI chr 4:43,447,724...43,455,102
Ensembl chr 4:43,446,462...43,454,628
JBrowse link
G Cdkn2a cyclin dependent kinase inhibitor 2A multiple interactions ISO [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in increased methylation of CDKN2A gene CTD PMID:26778509 NCBI chr 4:89,274,473...89,294,619
Ensembl chr 4:89,274,471...89,294,653
JBrowse link
G Crp C-reactive protein, pentraxin-related increases expression ISO Nitrogen Dioxide results in increased expression of CRP protein CTD PMID:18629312 PMID:22306530 NCBI chr 1:172,698,056...172,699,966
Ensembl chr 1:172,698,055...172,833,031
JBrowse link
G Csde1 cold shock domain containing E1, RNA binding increases expression ISO Nitrogen Dioxide results in increased expression of CSDE1 mRNA CTD PMID:27206323 NCBI chr 3:103,020,431...103,058,186
Ensembl chr 3:103,020,426...103,058,186
JBrowse link
G Csf2 colony stimulating factor 2 (granulocyte-macrophage) increases secretion ISO Nitrogen Dioxide results in increased secretion of CSF2 protein CTD PMID:8398164 NCBI chr11:54,247,270...54,249,899
Ensembl chr11:54,247,271...54,249,667
JBrowse link
G Cxcl15 chemokine (C-X-C motif) ligand 15 increases expression
increases secretion
ISO Nitrogen Dioxide results in increased expression of CXCL8 mRNA
Nitrogen Dioxide results in increased secretion of CXCL8 protein
CTD PMID:8398164 PMID:8584542 PMID:22331494 PMID:27206323 NCBI chr 5:90,794,534...90,803,067
Ensembl chr 5:90,794,534...90,803,067
JBrowse link
G Cxcl2 chemokine (C-X-C motif) ligand 2 multiple interactions
increases expression
ISO
EXP
[Ozone co-treated with Nitrogen Dioxide] results in increased expression of CXCL2 mRNA
Nitrogen Dioxide results in increased expression of CXCL2 mRNA; Nitrogen Dioxide results in increased expression of CXCL2 protein
CTD PMID:10715624 PMID:10986008 PMID:11498801 NCBI chr 5:90,903,899...90,905,938
Ensembl chr 5:90,903,871...90,905,938
JBrowse link
G Dgkk diacylglycerol kinase kappa increases expression ISO Nitrogen Dioxide results in increased expression of DGKK mRNA CTD PMID:27206323 NCBI chr  X:6,779,306...6,948,363
Ensembl chr  X:6,779,306...6,948,363
JBrowse link
G Dnm1l dynamin 1-like multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of DNM1L protein CTD PMID:27521637 NCBI chr16:16,312,228...16,359,038
Ensembl chr16:16,312,230...16,358,959
JBrowse link
G Drd2 dopamine receptor D2 increases expression ISO Nitrogen Dioxide results in increased expression of DRD2 mRNA CTD PMID:19733627 NCBI chr 9:49,340,360...49,408,177
Ensembl chr 9:49,340,627...49,408,177
JBrowse link
G E2f2 E2F transcription factor 2 decreases activity EXP Nitrogen Dioxide results in decreased activity of E2F2 protein CTD PMID:12600834 NCBI chr 4:136,172,274...136,196,057
Ensembl chr 4:136,172,394...136,196,057
JBrowse link
G Edn1 endothelin 1 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of EDN1 protein CTD PMID:30090456 NCBI chr13:42,301,476...42,307,990
Ensembl chr13:42,301,476...42,307,990
JBrowse link
G Ephb2 Eph receptor B2 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of EPHB2 gene CTD PMID:28843141 NCBI chr 4:136,647,536...136,836,326
Ensembl chr 4:136,647,539...136,835,988
JBrowse link
G Faap20 Fanconi anemia core complex associated protein 20 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of FAAP20 gene CTD PMID:29935799 NCBI chr 4:155,246,904...155,256,687
Ensembl chr 4:155,249,802...155,256,687
JBrowse link
G Fam124b family with sequence similarity 124, member B multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of FAM124B gene CTD PMID:29935799 NCBI chr 1:80,198,699...80,214,205
Ensembl chr 1:80,198,706...80,218,473
JBrowse link
G Fis1 fission, mitochondrial 1 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of FIS1 protein CTD PMID:27521637 NCBI chr 5:136,953,275...136,966,234
Ensembl chr 5:136,953,275...136,966,234
JBrowse link
G Fos FBJ osteosarcoma oncogene increases expression ISO Nitrogen Dioxide results in increased expression of FOS protein CTD PMID:22621880 NCBI chr12:85,473,890...85,477,274
Ensembl chr12:85,473,890...85,477,273
JBrowse link
G Foxm1 forkhead box M1 increases expression ISO Nitrogen Dioxide results in increased expression of FOXM1 mRNA CTD PMID:27206323 NCBI chr 6:128,362,994...128,375,886
Ensembl chr 6:128,362,967...128,376,146
JBrowse link
G Foxp3 forkhead box P3 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in increased methylation of FOXP3 promoter CTD PMID:29317916 NCBI chr  X:7,579,676...7,595,243
Ensembl chr  X:7,573,644...7,595,245
JBrowse link
G Gclm glutamate-cysteine ligase, modifier subunit decreases expression ISO Nitrogen Dioxide results in decreased expression of GCLM mRNA CTD PMID:16049373 NCBI chr 3:122,245,487...122,267,215
Ensembl chr 3:122,245,557...122,270,732
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 increases expression
multiple interactions
ISO Nitrogen Dioxide results in increased expression of GGT1 mRNA
Nitrogen Dioxide results in increased expression of and results in increased activity of GGT1 protein
CTD PMID:9144455 PMID:16049373 NCBI chr10:75,561,076...75,586,193
Ensembl chr10:75,561,604...75,586,200
JBrowse link
G Gpr55 G protein-coupled receptor 55 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased expression of GPR55 mRNA; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in decreased expression of GPR55 mRNA CTD PMID:27448387 NCBI chr 1:85,933,221...85,991,583
Ensembl chr 1:85,938,318...85,961,007
JBrowse link
G Gpx3 glutathione peroxidase 3 increases expression
decreases expression
ISO Nitrogen Dioxide results in increased expression of GPX3 mRNA
Nitrogen Dioxide results in decreased expression of GPX3 mRNA
CTD PMID:15336314 PMID:16049373 NCBI chr11:54,902,854...54,910,387
Ensembl chr11:54,902,453...54,910,377
JBrowse link
G Gpx4 glutathione peroxidase 4 affects expression ISO Nitrogen Dioxide affects the expression of GPX4 mRNA CTD PMID:16049373 NCBI chr10:80,047,166...80,056,439
Ensembl chr10:80,047,166...80,056,439
JBrowse link
G Gpx5 glutathione peroxidase 5 increases expression ISO Nitrogen Dioxide results in increased expression of GPX5 mRNA CTD PMID:27206323 NCBI chr13:21,286,429...21,292,727
Ensembl chr13:21,286,429...21,292,731
JBrowse link
G Gsr glutathione reductase increases activity
increases expression
ISO Nitrogen Dioxide results in increased activity of GSR protein
Nitrogen Dioxide results in increased expression of GSR mRNA
CTD PMID:16049373 NCBI chr 8:33,653,238...33,698,162
Ensembl chr 8:33,652,523...33,698,163
JBrowse link
G Gss glutathione synthetase decreases expression ISO Nitrogen Dioxide results in decreased expression of GSS mRNA CTD PMID:16049373 NCBI chr 2:155,563,181...155,592,810
Ensembl chr 2:155,563,181...155,592,810
JBrowse link
G Gstm1 glutathione S-transferase, mu 1 affects response to substance ISO GSTM1 gene polymorphism affects the susceptibility to Nitrogen Dioxide CTD PMID:22732554 NCBI chr 3:108,012,250...108,017,973
Ensembl chr 3:108,012,255...108,017,973
JBrowse link
G Gstp1 glutathione S-transferase, pi 1 affects response to substance
multiple interactions
ISO GSTP1 gene polymorphism affects the susceptibility to Nitrogen Dioxide
GSTP1 gene SNP results in increased susceptibility to [[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Nitrogen Dioxide]
CTD PMID:22732554 PMID:29624745 NCBI chr19:4,035,411...4,037,912
Ensembl chr19:4,035,407...4,037,985
JBrowse link
G Gstt1 glutathione S-transferase, theta 1 affects response to substance ISO GSTT1 gene polymorphism affects the susceptibility to Nitrogen Dioxide CTD PMID:22732554 NCBI chr10:75,783,813...75,798,584
Ensembl chr10:75,783,813...75,798,584
JBrowse link
G Hibadh 3-hydroxyisobutyrate dehydrogenase multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of HIBADH gene; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of HIBADH gene CTD PMID:27448387 NCBI chr 6:52,546,230...52,640,300
Ensembl chr 6:52,546,228...52,640,389
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
decreases expression
EXP
ISO
Nitrogen Dioxide results in increased expression of HMOX1 mRNA
Nitrogen Dioxide results in decreased expression of HMOX1 mRNA
CTD PMID:10715624 PMID:20197249 PMID:27206323 NCBI chr 8:75,093,618...75,100,593
Ensembl chr 8:75,093,621...75,100,589
JBrowse link
G Hsp90aa1 heat shock protein 90, alpha (cytosolic), class A member 1 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of HSP90AA1 gene CTD PMID:29935799 NCBI chr12:110,691,036...110,696,395
Ensembl chr12:110,690,605...110,702,728
JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression ISO Nitrogen Dioxide results in increased expression of ICAM1 mRNA CTD PMID:22331494 NCBI chr 9:21,015,940...21,028,814
Ensembl chr 9:21,015,985...21,028,817
JBrowse link
G Ifng interferon gamma multiple interactions
decreases expression
EXP [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitrogen Dioxide; [OVAL protein promotes the reaction [Nitrogen Dioxide results in increased susceptibility to OVAL protein]] which results in decreased expression of IFNG protein
Nitrogen Dioxide results in decreased expression of IFNG protein
CTD PMID:22303861 PMID:28935613 NCBI chr10:118,441,046...118,445,894
Ensembl chr10:118,441,046...118,445,892
JBrowse link
G Il10 interleukin 10 increases expression ISO Nitrogen Dioxide results in increased expression of IL10 mRNA; Nitrogen Dioxide results in increased expression of IL10 protein CTD PMID:28669936 NCBI chr 1:131,019,845...131,024,970
Ensembl chr 1:131,019,845...131,024,974
JBrowse link
G Il13 interleukin 13 decreases methylation
increases expression
multiple interactions
EXP
ISO
Nitrogen Dioxide results in decreased methylation of IL13 promoter
Nitrogen Dioxide results in increased expression of IL13 mRNA
Nitrogen Dioxide results in increased expression of IL13 protein
[OVAL protein promotes the reaction [Nitrogen Dioxide results in increased susceptibility to OVAL protein]] which results in increased expression of IL13 protein
CTD PMID:28669936 PMID:28935613 NCBI chr11:53,631,323...53,634,702
Ensembl chr11:53,631,324...53,634,702
JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases expression
ISO [Ozone co-treated with Nitrogen Dioxide] results in increased expression of IL1B protein
IL1B gene SNP results in increased susceptibility to [[Air Pollutants results in increased abundance of Vehicle Emissions] which results in increased abundance of Nitrogen Dioxide]
Nitrogen Dioxide results in decreased expression of IL1B mRNA
CTD PMID:9363475 PMID:10986008 PMID:27640071 NCBI chr 2:129,364,569...129,371,164
Ensembl chr 2:129,364,570...129,371,139
JBrowse link
G Il4 interleukin 4 increases expression
multiple interactions
decreases methylation
EXP Nitrogen Dioxide results in increased expression of IL4 protein
[[OVAL protein promotes the reaction [Nitrogen Dioxide results in increased susceptibility to OVAL protein]] which results in decreased methylation of IL4 promoter] which results in increased expression of IL4 protein; [Nitrogen Dioxide results in decreased methylation of IL4 gene] which results in increased expression of IL4 promoter; [OVAL protein promotes the reaction [Nitrogen Dioxide results in increased susceptibility to OVAL protein]] which results in decreased methylation of IL4 promoter; [OVAL protein promotes the reaction [Nitrogen Dioxide results in increased susceptibility to OVAL protein]] which results in increased expression of IL4 protein
Nitrogen Dioxide results in decreased methylation of IL4 promoter
CTD PMID:28935613 NCBI chr11:53,612,460...53,618,665
Ensembl chr11:53,602,982...53,618,669
JBrowse link
G Il6 interleukin 6 multiple interactions
decreases expression
increases secretion
increases expression
ISO [Ozone co-treated with Nitrogen Dioxide] results in increased expression of IL6 protein
Nitrogen Dioxide results in decreased expression of IL6 mRNA
Nitrogen Dioxide results in increased secretion of IL6 protein
Nitrogen Dioxide results in increased expression of IL6 mRNA; Nitrogen Dioxide results in increased expression of IL6 protein
CTD PMID:8584542 PMID:10986008 PMID:18629312 PMID:19750100 PMID:27206323 PMID:28669936 NCBI chr 5:30,013,114...30,019,975
Ensembl chr 5:30,013,114...30,019,981
JBrowse link
G Ipcef1 interaction protein for cytohesin exchange factors 1 decreases expression ISO Nitrogen Dioxide results in decreased expression of IPCEF1 mRNA CTD PMID:27206323 NCBI chr10:6,885,779...7,054,782
Ensembl chr10:6,885,796...7,052,478
JBrowse link
G Jun jun proto-oncogene increases expression ISO Nitrogen Dioxide results in increased expression of JUN protein CTD PMID:22621880 NCBI chr 4:95,049,036...95,052,222
Ensembl chr 4:95,049,034...95,052,222
JBrowse link
G Lmf1 lipase maturation factor 1 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of LMF1 gene CTD PMID:29935799 NCBI chr17:25,579,174...25,662,831
Ensembl chr17:25,579,085...25,662,826
JBrowse link
G Lonp1 lon peptidase 1, mitochondrial multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of LONP1 gene; [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in increased expression of LONP1 mRNA; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of LONP1 gene; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in increased expression of LONP1 mRNA CTD PMID:27448387 NCBI chr17:56,614,297...56,626,903
Ensembl chr17:56,614,297...56,626,887
JBrowse link
G Lztfl1 leucine zipper transcription factor-like 1 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of LZTFL1 gene CTD PMID:29935799 NCBI chr 9:123,694,404...123,717,625
Ensembl chr 9:123,694,416...123,717,697
JBrowse link
G Mcf2l mcf.2 transforming sequence-like multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of MCF2L gene CTD PMID:28843141 NCBI chr 8:12,873,806...13,020,502
Ensembl chr 8:12,873,806...13,020,905
JBrowse link
G Meis2 Meis homeobox 2 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of MEIS2 gene CTD PMID:28843141 NCBI chr 2:115,861,264...116,067,537
Ensembl chr 2:115,863,064...116,065,839
JBrowse link
G Mfn1 mitofusin 1 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MFN1 protein CTD PMID:27521637 NCBI chr 3:32,529,443...32,579,225
Ensembl chr 3:32,529,465...32,579,239
JBrowse link
G Mfn2 mitofusin 2 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MFN2 protein CTD PMID:27521637 NCBI chr 4:147,873,586...147,904,909
Ensembl chr 4:147,873,599...147,904,704
JBrowse link
G Mgst3 microsomal glutathione S-transferase 3 increases expression ISO Nitrogen Dioxide results in increased expression of MGST3 mRNA CTD PMID:27206323 NCBI chr 1:167,371,966...167,393,841
Ensembl chr 1:167,371,966...167,393,841
JBrowse link
G Mir1249 microRNA 1249 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of MIR1249 mRNA CTD PMID:30090456 NCBI chr15:84,951,526...84,951,623
Ensembl chr15:84,951,526...84,951,623
JBrowse link
G Mir185 microRNA 185 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR185 mRNA CTD PMID:30090456 NCBI chr16:18,327,401...18,327,465
Ensembl chr16:18,327,401...18,327,465
JBrowse link
G Mir1894 microRNA 1894 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR1894 mRNA CTD PMID:30090456 NCBI chr17:35,917,889...35,917,969
Ensembl chr17:35,917,889...35,917,969
JBrowse link
G Mir1927 microRNA 1927 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR1927 mRNA CTD PMID:30090456 NCBI chr 1:160,295,864...160,295,972
Ensembl chr 1:160,295,864...160,295,972
JBrowse link
G Mir205 microRNA 205 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of MIR205 mRNA CTD PMID:30090456 NCBI chr 1:193,507,463...193,507,530
Ensembl chr 1:193,507,463...193,507,530
JBrowse link
G Mir3070b microRNA 3070b multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR3070B mRNA CTD PMID:30090456 NCBI chr12:109,588,592...109,588,680
Ensembl chr12:109,588,592...109,588,680
JBrowse link
G Mir3095 microRNA 3095 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR3095 mRNA CTD PMID:30090456 NCBI chr 4:58,441,012...58,441,098
Ensembl chr 4:58,441,012...58,441,098
JBrowse link
G Mir30e microRNA 30e multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of MIR30E mRNA CTD PMID:30090456 NCBI chr 4:120,772,606...120,772,697
Ensembl chr 4:120,772,606...120,772,697
JBrowse link
G Mir338 microRNA 338 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR338 mRNA CTD PMID:30090456 NCBI chr11:120,014,765...120,014,862
Ensembl chr11:120,014,765...120,014,862
JBrowse link
G Mir34b microRNA 34b multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of MIR34B mRNA CTD PMID:30090456 NCBI chr 9:51,103,562...51,103,645
Ensembl chr 9:51,103,562...51,103,645
JBrowse link
G Mir374c microRNA 374c multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR374C mRNA CTD PMID:30090456 NCBI chr  X:103,573,085...103,573,133
Ensembl chr  X:103,573,085...103,573,133
JBrowse link
G Mir375 microRNA 375 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR375 mRNA CTD PMID:30090456 NCBI chr 1:74,900,658...74,900,721
Ensembl chr 1:74,900,658...74,900,721
JBrowse link
G Mir425 microRNA 425 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR425 mRNA CTD PMID:30090456 NCBI chr 9:108,568,777...108,568,861
Ensembl chr 9:108,568,777...108,568,861
JBrowse link
G Mir434 microRNA 434 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of MIR434 mRNA CTD PMID:30090456 NCBI chr12:109,594,506...109,594,599
Ensembl chr12:109,594,506...109,594,599
JBrowse link
G Mir450b microRNA 450b multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR450B mRNA CTD PMID:30090456 NCBI chr  X:53,047,997...53,048,078
Ensembl chr  X:53,047,997...53,048,078
JBrowse link
G Mir500 microRNA 500 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR500 mRNA CTD PMID:30090456 NCBI chr  X:7,237,683...7,237,774
Ensembl chr  X:7,237,683...7,237,774
JBrowse link
G Mir504 microRNA 504 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR504 mRNA CTD PMID:30090456 NCBI chr  X:59,097,658...59,097,736
Ensembl chr  X:59,097,658...59,097,736
JBrowse link
G Mir674 microRNA 674 multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIR674 mRNA CTD PMID:30090456 NCBI chr 2:117,185,127...117,185,226
Ensembl chr 2:117,185,127...117,185,226
JBrowse link
G Mirlet7e microRNA let7e multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of MIRLET7E mRNA CTD PMID:30090456 NCBI chr17:17,830,352...17,830,444
Ensembl chr17:17,830,352...17,830,444
JBrowse link
G Mpo myeloperoxidase increases expression ISO Nitrogen Dioxide results in increased expression of MPO mRNA CTD PMID:27206323 NCBI chr11:87,793,784...87,804,412
Ensembl chr11:87,793,581...87,804,413
JBrowse link
G Mt3 metallothionein 3 increases expression ISO Nitrogen Dioxide results in increased expression of MT3 mRNA CTD PMID:27206323 NCBI chr 8:94,152,607...94,154,148
Ensembl chr 8:94,152,607...94,154,146
JBrowse link
G Nos2 nitric oxide synthase 2, inducible increases expression
multiple interactions
EXP
ISO
Nitrogen Dioxide results in increased expression of NOS2 mRNA
[Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in increased methylation of NOS2 gene
CTD PMID:10715624 PMID:26778509 NCBI chr11:78,920,787...78,960,226
Ensembl chr11:78,920,787...78,960,254
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of NOS3 protein CTD PMID:30090456 NCBI chr 5:24,364,816...24,384,474
Ensembl chr 5:24,364,810...24,384,474
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 affects response to substance ISO NQO1 gene polymorphism affects the susceptibility to Nitrogen Dioxide CTD PMID:20049212 NCBI chr 8:107,388,225...107,403,205
Ensembl chr 8:107,388,225...107,403,206
JBrowse link
G Nudt1 nudix (nucleoside diphosphate linked moiety X)-type motif 1 increases expression ISO Nitrogen Dioxide results in increased expression of NUDT1 mRNA CTD PMID:27206323 NCBI chr 5:140,321,622...140,338,137
Ensembl chr 5:140,321,656...140,338,137
JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase multiple interactions EXP [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of OPA1 protein CTD PMID:27521637 NCBI chr16:29,579,281...29,663,127
Ensembl chr16:29,579,334...29,654,884
JBrowse link
G P2rx4 purinergic receptor P2X, ligand-gated ion channel 4 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of P2RX4 gene CTD PMID:29935799 NCBI chr 5:122,707,518...122,729,739
Ensembl chr 5:122,707,544...122,729,738
JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression EXP Nitrogen Dioxide results in decreased expression of PCNA protein CTD PMID:12600834 NCBI chr 2:132,249,286...132,253,180
Ensembl chr 2:132,249,162...132,253,314
JBrowse link
G Piezo1 piezo-type mechanosensitive ion channel component 1 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of PIEZO1 gene CTD PMID:29935799 NCBI chr 8:122,481,698...122,551,329
Ensembl chr 8:122,481,698...122,551,329
JBrowse link
G Pla2g7 phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) affects expression ISO Nitrogen Dioxide affects the expression of PLA2G7 CTD PMID:21356620 NCBI chr17:43,567,994...43,612,202
Ensembl chr17:43,568,098...43,612,201
JBrowse link
G Prex1 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 increases expression ISO Nitrogen Dioxide results in increased expression of PREX1 mRNA CTD PMID:27206323 NCBI chr 2:166,566,345...166,713,832
Ensembl chr 2:166,566,342...166,713,832
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression ISO Nitrogen Dioxide results in increased expression of PTGS2 mRNA CTD PMID:27206323 NCBI chr 1:150,100,031...150,108,234
Ensembl chr 1:150,100,031...150,108,227
JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases phosphorylation EXP Nitrogen Dioxide results in decreased phosphorylation of RB1 protein CTD PMID:12600834 NCBI chr14:73,192,858...73,325,951
Ensembl chr14:73,183,673...73,325,822
JBrowse link
G Rnf2 ring finger protein 2 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of RNF2 5' UTR CTD PMID:28843141 NCBI chr 1:151,469,398...151,500,991
Ensembl chr 1:151,458,004...151,500,955
JBrowse link
G Selp selectin, platelet increases expression ISO Nitrogen Dioxide results in increased expression of SELP protein modified form CTD PMID:18629312 NCBI chr 1:164,115,264...164,150,026
Ensembl chr 1:164,115,264...164,150,026
JBrowse link
G Slc25a28 solute carrier family 25, member 28 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in increased methylation of SLC25A28 gene; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in increased methylation of SLC25A28 gene CTD PMID:27448387 NCBI chr19:43,663,801...43,675,006
Ensembl chr19:43,663,801...43,674,881
JBrowse link
G Sod1 superoxide dismutase 1, soluble increases expression
decreases activity
decreases expression
multiple interactions
ISO Nitrogen Dioxide results in increased expression of SOD1 mRNA
Nitrogen Dioxide results in decreased activity of SOD1 protein
Nitrogen Dioxide results in decreased expression of SOD1 protein
[[SOD1 protein results in increased metabolism of Hydrogen Peroxide] which results in increased oxidation of Nitrites] which results in increased chemical synthesis of Nitrogen Dioxide
CTD PMID:15336314 PMID:18629312 PMID:19243126 PMID:22621880 NCBI chr16:90,220,762...90,226,333
Ensembl chr16:90,220,754...90,226,329
JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial decreases activity
multiple interactions
ISO Nitrogen Dioxide results in decreased activity of SOD2 protein
[[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of SOD2 promoter] which affects the methylation of SOD2 promoter; [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of SOD2 promoter
CTD PMID:22621880 PMID:31220783 NCBI chr17:13,007,839...13,018,119
Ensembl chr17:13,006,846...13,040,063
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO [Ozone co-treated with Nitrogen Dioxide] results in increased expression of TGFB1 mRNA CTD PMID:10986008 NCBI chr 7:25,687,002...25,705,077
Ensembl chr 7:25,687,002...25,705,077
JBrowse link
G Thap1 THAP domain containing, apoptosis associated protein 1 multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of THAP1 3' UTR CTD PMID:28843141 NCBI chr 8:26,158,169...26,164,151
Ensembl chr 8:26,158,141...26,164,151
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
increases secretion
decreases secretion
affects response to substance
ISO [Ozone co-treated with Nitrogen Dioxide] results in increased expression of TNF protein
TNF gene SNP results in increased susceptibility to [[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Nitrogen Dioxide]
Nitrogen Dioxide results in increased expression of TNF mRNA
Nitrogen Dioxide results in increased secretion of TNF protein
Nitrogen Dioxide results in decreased secretion of TNF protein
TNF gene polymorphism affects the susceptibility to Nitrogen Dioxide
CTD PMID:8398164 PMID:9363475 PMID:10986008 PMID:20049212 PMID:28669936 PMID:29624745 NCBI chr17:35,199,367...35,202,007
Ensembl chr17:35,199,381...35,202,007
JBrowse link
G Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b increases expression ISO Nitrogen Dioxide results in increased expression of TNFRSF1B protein modified form CTD PMID:18629312 NCBI chr 4:145,212,368...145,246,870
Ensembl chr 4:145,213,463...145,246,870
JBrowse link
G Tpo thyroid peroxidase multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of TPO gene; [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in increased expression of TPO mRNA; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of TPO gene; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in increased expression of TPO mRNA CTD PMID:27448387 NCBI chr12:30,054,659...30,132,984
Ensembl chr12:30,054,659...30,132,624
JBrowse link
G Trmt10a tRNA methyltransferase 10A multiple interactions ISO [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in increased methylation of TRMT10A CTD PMID:28843141 NCBI chr 3:138,143,448...138,159,821
Ensembl chr 3:138,143,448...138,159,821
JBrowse link
G Trp53 transformation related protein 53 increases expression
multiple interactions
ISO
EXP
Nitrogen Dioxide results in increased expression of TP53 mRNA; Nitrogen Dioxide results in increased expression of TP53 protein
[Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of TRP53 protein
CTD PMID:22621880 PMID:27521637 NCBI chr11:69,580,348...69,591,873
Ensembl chr11:69,580,359...69,591,873
JBrowse link
G Ttn titin increases expression ISO Nitrogen Dioxide results in increased expression of TTN mRNA CTD PMID:27206323 NCBI chr 2:76,703,980...76,982,557
Ensembl chr 2:76,703,980...76,982,547
JBrowse link
G Txn1 thioredoxin 1 multiple interactions ISO [Ozone co-treated with Nitrogen Dioxide] results in increased expression of TXN1 mRNA CTD PMID:10986008 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
JBrowse link
G Txndc2 thioredoxin domain containing 2 (spermatozoa) increases expression ISO Nitrogen Dioxide results in increased expression of TXNDC2 mRNA CTD PMID:27206323 NCBI chr17:65,637,505...65,648,874
Ensembl chr17:65,637,507...65,642,168
JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression ISO Nitrogen Dioxide results in increased expression of TXNRD1 mRNA CTD PMID:27206323 NCBI chr10:82,833,951...82,897,724
Ensembl chr10:82,833,951...82,897,712
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 increases expression ISO Nitrogen Dioxide results in increased expression of VCAM1 mRNA CTD PMID:22331494 NCBI chr 3:116,110,020...116,129,688
Ensembl chr 3:116,109,949...116,129,688
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 21560
    chemical entity 21558
      molecular entity 21543
        inorganic molecular entity 21206
          inorganic oxide 7717
            nitrogen oxide 414
              1,2-dinitrosodioxidane 0
              bis(oxidonitrate)(N--N)(.1-) 0
              dinitrogen oxide 9
              dinitrogen pentaoxide 0
              dinitrogen tetraoxide 0
              dinitrogen trioxide 0
              dioxidonitrate(.2-) 0
              dioxidonitrogen(1+) 0
              dioxohydrazine 0
              mu-oxidobis(oxidonitrogen) 0
              nitric oxide 320
              nitrogen dioxide 119
              nitrooxidanyl 0
              oxidonitrate(1-) 0
              oxidonitrate(2.1-) (triplet) 0
              oxidonitrogen(1+) 0
              trioxido-1kappa(2)O,2kappaO-dinitrate(N--N)(2-) 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 21560
    subatomic particle 21546
      composite particle 21546
        hadron 21546
          baryon 21546
            nucleon 21546
              atomic nucleus 21546
                atom 21546
                  main group element atom 21449
                    p-block element atom 21449
                      chalcogen 20518
                        oxygen atom 20496
                          oxygen molecular entity 20496
                            oxide 12245
                              inorganic oxide 7717
                                nitrogen oxide 414
                                  1,2-dinitrosodioxidane 0
                                  bis(oxidonitrate)(N--N)(.1-) 0
                                  dinitrogen oxide 9
                                  dinitrogen pentaoxide 0
                                  dinitrogen tetraoxide 0
                                  dinitrogen trioxide 0
                                  dioxidonitrate(.2-) 0
                                  dioxidonitrogen(1+) 0
                                  dioxohydrazine 0
                                  mu-oxidobis(oxidonitrogen) 0
                                  nitric oxide 320
                                  nitrogen dioxide 119
                                  nitrooxidanyl 0
                                  oxidonitrate(1-) 0
                                  oxidonitrate(2.1-) (triplet) 0
                                  oxidonitrogen(1+) 0
                                  trioxido-1kappa(2)O,2kappaO-dinitrate(N--N)(2-) 0
paths to the root